1 2 Steroid hormone synthesis in mitochondria 3 Walter L . Miller ⇑ Q1 4 Department of Pediatrics , University of California San Francisco , San Francisco , CA 94143 - 1346 , USA Q2 5 Division of Endocrinology , University of California San Francisco , San Francisco , CA 94143 - 1346 , USA 6 8 a r t i c l e i n f o 9 Article history : 10 Available online xxxx 11 Keywords Q4 : 12 Cholesterol transport 13 Cholesterol side chain cleavage 14 Outer mitochondrial membrane 15 Steroidogenesis 16 Steroidogenic acute regulatory protein 17 TSPO 18 1 9 a b s t r a c t 20 Mitochondria are essential sites for steroid hormone biosynthesis . Mitochondria in the steroidogenic cells 21 of the adrenal , gonad , placenta and brain contain the cholesterol side - chain cleavage enzyme , P450scc , 22 and its two electron - transfer partners , ferredoxin reductase and ferredoxin . This enzyme system converts 23 cholesterol to pregnenolone and determines net steroidogenic capacity , so that it serves as the chronic 24 regulator of steroidogenesis . Several other steroidogenic enzymes , including 3 b - hydroxysteroid dehydro - 25 genase , 11 b - hydroxylase and aldosterone synthase also reside in mitochondria . Similarly , the mitochon - 26 dria of renal tubular cells contain two key enzymes participating in the activation and degradation of 27 vitamin D . The access of cholesterol to the mitochondria is regulated by the steroidogenic acute regula - 28 tory protein , StAR , serving as the acute regulator of steroidogenesis . StAR action requires a complex 29 multi - component molecular machine on the outer mitochondrial membrane ( OMM ) . Components of this 30 machine include the 18 kDa translocator protein ( TSPO ) , the voltage - dependent anion chanel ( VDAC - 1 ) , 31 TSPO - associated protein 7 ( PAP7 , ACBD3 ) , and protein kinase A regulatory subunit 1 a ( PKAR1A ) . The pre - 32 cise fashion in which these proteins interact and move cholesterol from the OMM to P450scc , and the 33 means by which cholesterol is loaded into the OMM , remain unclear . Human deﬁciency diseases have 34 been described for StAR and for all the mitochondrial steroidogenic enzymes , but not for the electron 35 transfer proteins or for the components of the cholesterol import machine . 36 (cid:2) 2013 Elsevier Ireland Ltd . All rights reserved . 37 38 3940 1 . Introduction 41 Six classes of steroid hormones , all of which are indispensable 42 for mammalian life , are made from cholesterol via complex 43 biosynthetic pathways that are initiated by specialized , tissue - 44 speciﬁc enzymes found in mitochondria . These hormones include 45 glucocorticoids ( cortisol , corticosterone ) and mineralocorticoids 46 ( aldosterone ) produced in the adrenal cortex ; estrogens ( estradiol ) , 47 progestins ( progesterone ) and androgens ( testosterone , dihydro - 48 testosterone ) produced in the gonads ; and calciferols ( 1 , 25 - dihy - 49 droxy vitamin D [ 1 , 25OH 2 D ] ) produced in the kidney . The 50 biosynthesis of the steroid hormones ( Miller and Auchus , 2011 ) 51 and of 1 , 25OH 2 D ( a sterol ) ( Feldman et al . , 2013 ) from cholesterol 52 have been reviewed recently . There are two specialized aspects to 53 the mitochondria of these steroidogenic tissues – the specialized 54 mechanisms by which cholesterol is delivered to the mitochondria 55 and the specialized intra - mitochondrial enzymes that paricipate in 56 the synthesis of hormonal steroids . 57 2 . Delivery of cholesterol to mitochondria 58 2 . 1 . Sources of cholesterol 59 The intracellular transport and distribution of cholesterol prior 60 to its delivery to the mitochondria has been reviewed recently 61 ( Miller and Bose , 2011 ) . Cholesterol may be produced de novo from 62 acetate via a complex pathway primarily found in the endoplasmic 63 reticulum ( ER ) ( Porter and Herman , 2011 ) , but most steroidogenic 0303 - 7207 / $ - see front matter (cid:2) 2013 Elsevier Ireland Ltd . All rights reserved . http : / / dx . doi . org / 10 . 1016 / j . mce . 2013 . 04 . 014 Abbreviations : 1 , 25 ( OH ) 2 D , 1 , 25 dihydroxy vitamin D ( calcitriol ) ; 3 b HSD , 3 b - hydroxysteroid dehydrogenase ; ACAT , acyl transferase ; ACTH , adrenocor - ticotropic hormone ; ANT , adenine nucleotide transporter ; ER , endoplasmic reticulum ; CRAC , cholesterol recognition amino acid consensus domain ; FAD , ﬂavin adenine dinucleotide ; HDL , high density lipoproteis ; HSL , hormone - sensitive neutral lipase ; HMGCoA , 3 - hydroxy - 3 - methylglutaryl co - enzyme A ; IMM , inner mitochondrial membrane ; IMS , intramembranous space ; Km , Michaelis constant ; LAL , lysosomal acid lipase ; LDL , low - density lipoproteins ; LH , luteinizing hormone ; MENTAL , MLN64N - terminal ; MENTHO , MLN64N - terminal domain homologue ; MLN64 , metastatic lymph node clone 64 ; NADPH , nicotinamide adenine dinucleotide phosphate ; NPC , Niemann Pick type C ; OMM , outer mitochondrial membrane ; PAP7 , TSPO - associated protein 7 ( ACBD3 ) ; PBR , peripheral benzodiazepine receptor ; PCP , phosphate carrier protein ; PKA , protein kinase A ; PKAR1A , protein kinase A regulatory subunit 1 a ; PRAX1 , TSPO - associated protein 1 ; PTH , parathyroid hormone ; P450scc , mitochondrial cytochrome P450 speciﬁc for cholesterol side - chain cleavage ; SF1 , steroidogenic factor 1 ; SOAT , sterol O - acetyltransferase ; SR - B1 , scavenger receptor B1 ; StAR , steroidogenic acute regulatory protein ; START , StAR - related lipid transfer domain ; SREBPs , sterol regulatory element binding proteins ; TSPO , 18 kDa translocator protein ; VDAC1 , voltage - dependent anion channel . ⇑ Address : Dep Q3 artment of Pediatrics , University of California San Francisco , San Francisco , CA 94143 - 1346 , USA . E - mail address : wlmlab @ ucsf . edu Molecular and Cellular Endocrinology xxx ( 2013 ) xxx – xxx Contents lists available at SciVerse ScienceDirect Molecular and Cellular Endocrinology journal homepage : www . elsevier . com / locate / mce MCE 8497 No . of Pages 11 , Model 5G 4 May 2013 Please cite this article in press as : Miller , W . L . Steroid hormone synthesis in mitochondria . Molecular and Cellular Endocrinology ( 2013 ) , http : / / dx . doi . org / 10 . 1016 / j . mce . 2013 . 04 . 014 64 cholesterol is derived from circulating lipoproteins . High density 65 lipoproteins ( HDLs ) may be taken up via scavenger receptor B1 66 ( SR - B1 ) and low - density lipoproteins ( LDLs ) are taken up by 67 receptor - mediated endocytosis via LDL receptors . LDL can suppress 68 the rate - limiting enzyme in cholesterol synthesis , 3 - hydroxy - 69 3 - methylglutaryl co - enzyme A ( HMGCoA ) reductase . Rodents 70 preferentialy use the HDL / SR - B1 pathway to obtain steroidogenic 71 cholesterol , but the principal human source is receptor - mediated 72 endocytosis of LDL . Nevertheless , patients with congenital abeta - 73 lipoproteinemia have low LDL cholesterol but have normal basal 74 cortisol concentrations , and only mildly impaired cortisol re - 75 sponses to adrenocorticotropic hormone ( ACTH ) ( Illingworth 76 et al . , 1982 ) , and those treated with high doses of statins have no 77 impairment of cortisol secretion ( Dobs et al . , 2000 ) . Thus endoge - 78 nously produced cholesterol is sufﬁcient in most situations , and 79 the HDL / SR - B1 system plays a relatively minor role in human ste - 80 roidogenesis . The regulation of cholesterol uptake , intracellular 81 transport , and utilization is coordinated by a family of basic 82 helix - loop - helix transcription factors called the sterol regulatory 83 element binding proteins ( SREBPs ) . The cell biology of intracellular 84 cholesterol trafﬁcking is summarized in Fig . 1 . 85 2 . 2 . Lipases and the processing of cholesterol esters 86 After circulating LDL is internalized by receptor - mediated endo - 87 cytosis , the resulting endocytic vesicles fuse with lysosomes , 88 where the LDL proteins are degraded by proteolysis , liberating 89 the cholesteryl esters , which are then hydrolyzed to ‘free’ choles - 90 terol by lysosomal acid lipase ( LAL ) . However , cholesterol is never 91 truly free , as its solubility is only about 20 l mol per liter , so that 92 the term ‘free cholesterol’ refers to cholesterol that is bound to 93 proteins or membranes , but lacks a covalently linked group . Free 94 cholesterol may be used by the cell or stored in lipid droplets 95 following re - esteriﬁcation by acyl - coenzyme - A - cholesterol - acyl - 96 transferase ( ACAT ) also known as sterol - O - acetyltransferase 97 ( SOAT1 ) . Similarly , HDL cholesteryl esters that enter the cell via 98 SR - B1 are acted on by hormone - sensitive neutral lipase ( HSL ) , fol - 99 lowing which the free cholesterol may also be used or re - esteriﬁed 100 for storage . ACTH and luteinizing hormone ( LH ) respectively in - 101 crease intracellular levels of cAMP in the adrenal and gonad , stim - 102 ulating HSL and inhibiting ACAT , thus increasing the availability of 103 free cholesterol for steroid hormone synthesis . ACTH , LH and other 104 factors that increase cAMP stimulate the activity of HMGCoA 105 reductase and the uptake of LDL cholesterol . When intracellular 106 cholesterol concentrations are high , the genes for the LDL receptor , 107 HMGCoA reductase and LAL are repressed while ACAT is induced , 108 thereby decreasing cholesterol uptake , synthesis and de - esteriﬁca - 109 tion . Conversely , when intracellular cholesterol concentrations are 110 low , this process is reversed . 111 Mutations in the LIPA gene encoding LAL cause Wolman disease , 112 characterized by visceral accumulation of cholesteryl esters and 113 triglycerides , with secondary adrenal insufﬁciency ; cholesterol 114 ester storage disease is a milder , adult variant ( Lohse et al . , 115 1999 ) . Affected infants quickly develop hepatosplenomegaly , mal - 116 absorptive malnutrition and developmental delay ; the diagnosis 117 may be suggested by calciﬁcation that outlines the adrenal glands , 118 and is established by ﬁnding deﬁcient lysosomal acid lipase activ - 119 ity in leukocytes , ﬁbroblasts or prenatal amniocytes . Bone marrow 120 transplantation may ameliorate the disease , but the mechanism is 121 unclear . In contrast to LAL , no known human disease is associated 122 with HSL deﬁciency . 123 2 . 3 . Endosomal processing of cholesterol 124 The entry and exit of cholesterol from lipid droplets involves 125 the NPC proteins , so named because their mutation causes 126 Niemann Pick type C ( NPC ) disease , which is characterized by 127 endosomal accumulation of LDL - cholesterol and glyco - 128 sphingolipids . Patients are normal in infancy but develop ataxia , 129 dementia , loss of speech and spasticity at 2 – 4 years , and usually Fig . 1 . Intracellular cholesterol trafﬁcing . Human steroidogenic cells take up circulating low - density lipoproteins ( LDLs ) by receptor - mediated endocytosis , directing the cholesterol to endosomes ; rodent cells utilize cholesterol from high - density lipoproteins ( HDLs ) via scavenger receptor B1 ( SRB1 ) . Cholesterol may also be synthesized from acetate in the ER . Cholesteryl esters are cleaved by lysosomal acid lipase ( LAL ) ; free cholesterol is then bound by NPC1 , transferred to NPC2 , and exported . The MLN64 / MENTHO system resides in the same endosomes as the NPC system , but its role in cholesterol trafﬁcking remains uncertain . Cholesterol may be re - esteriﬁed by acyl - CoA : cholesterol transferase ( ACAT ) and stored in lipid droplets as cholesteryl esters . Free cholesterol may be produced by hormone - sensitive lipase ( HSL ) . Cholesterol can reach the outer mitochondrial membrane ( OMM ) by non - vesicular means by utilizing START - domain proteins or other cholesterol transport proteins . Movement of cholesterol from the OMM to the inner mitochondrial membrane ( IMM ) requires a multi - protein complex on the OMM . In the adrenals and gonads , the steroidogenic acute regulatory protein , StAR , is responsible for the rapid movement of cholesterol from the OMM to the IMM , where it can be converted to pregnenolone by P450scc . ( (cid:2) WL Miller ) . 2 W . L . Miller / Molecular and Cellular Endocrinology xxx ( 2013 ) xxx – xxx MCE 8497 No . of Pages 11 , Model 5G 4 May 2013 Please cite this article in press as : Miller , W . L . Steroid hormone synthesis in mitochondria . Molecular and Cellular Endocrinology ( 2013 ) , http : / / dx . doi . org / 10 . 1016 / j . mce . 2013 . 04 . 014 130 die during their second decade ( Vanier and Millat , 2003 ) . Choles - 131 terol and other lipids accumulate in Purkinje cells and other neu - 132 rons , and there is robust glial inﬁltration . The diagnosis is 133 typically made by ﬁnding characteristic foamy Niemann - Pick cells 134 and ‘sea - blue’ histiocytes in the bone marrow . The NPC1 or NPC2 135 proteins participate in endosomal / lysosomal cholesterol transport . 136 NPC1 is a 1278 AA glycoprotein containing 13 transmembrane do - 137 mains that span the endo - lysosomal membrane ( Kwon et al . , 138 2009 ) , and NPC2 is a soluble 151 AA glycoprotein found in the lyso - 139 somal lumen ( Xu et al . , 2007 ) . NPC2 binds cholesteryl esters with 140 the cholesterol side - chain buried is in a hydrophobic pocket and 141 the polar 3 b OH group exposed , allowing LAL to cleave cholesteryl 142 esters while they are bound to NPC2 . The free cholesterol is then 143 transferred to the N - terminal domain of NPC1 in the lysosomal 144 lumen , which binds cholesterol the 3 b OH group buried in the 145 protein and the side chain partially exposed . Thus , the NPC2 and 146 NPC1 proteins act together to insert cholesterol into the lysosomal 147 membrane with the hydrophobic side - chain going in ﬁrst . 148 Two proteins named MLN64 ( metastatic lymph node clone 64 ) 149 and MENTHO ( MLN64N - terminal domain homologue ) may also 150 participate in endosomal cholesterol trafﬁcking . MLN64 is a 151 cholesterol - binding protein that co - localizes with NPC1 in late 152 endosomes ( Zhang et al . , 2002 ; Alpy and Tomasetto , 2006 ) . The 153 N - terminal ‘MENTAL’ domain ( for MLN64N - TerminAL ) is structur - 154 ally related to the late - endosomal protein , MENTHO ( Alpy et al . , 155 2002 ) , contains 4 transmembrane domains , and targets MLN64 to 156 late endosomal membranes . The C - terminal domain of MLN64 is 157 called the START ( StAR - related lipid transfer ) domain because it 158 is similar to the lipid - biding domain of the steroidogenic acute reg - 159 ulatory protein ( StAR ) ( Alpy et al . , 2001 ; Clark , 2012 ) ( see Section 160 3 ) . The MENTAL domains of MENTHO and MLN64 can interact to 161 form homo - and heterodimers and to bind cholesterol , suggesting 162 a role in endosomal cholesterol transport . MLN64 lacking the MEN - 163 TAL domain ( N - 234 MLN64 ) has 50 – 60 % of StAR - like activity to 164 stimulate mitochondrial uptake of cholesterol ( Bose et al . , 2000 ) . 165 The START domain of MLN64 may interact with cytoplasmic 166 HSP60 to stimulate steroidogenesis in placental mitochondria 167 ( Olvera - Sanchez et al . , 2011 ) . The function of MLN64 remains un - 168 clear : knockout of the START domain of MLN64 yielded viable , neu - 169 rologically intact , fertile mice with normal plasma and hepatic 170 lipids ( Kishida et al . , 2004 ) , and no human disorders of MLN64 or 171 MENTHO have been described . Accumulation of cholesterol in 172 NPC1 - deﬁcient cells increased MLN64 - mediated cholesterol trans - 173 port to mitochondria and accumulation of cholesterol in the outer 174 mitochondiral membrane ( OMM ) , suggesting that cholesterol 175 transport from endosomes to mitochondria may involve MLN64 176 ( Charman et al . , 2010 ) . 177 2 . 4 . Non - vesicular intracytoplasmic cholesterol transport 178 Intracellular cholesterol transport may may be ‘vesicular’ ( med - 179 iated by membrane fusion ) or ‘non - vesicular’ ( bound to proteins ) . 180 Because membranes participating in vesicular transport are ﬂuid , 181 the lipid compositions of the mitochondrial membranes may vary . 182 Protein - protein interactions between lipid droplets , mitochondria , 183 and other organelles may facilitate vesicular cholesterol transport . 184 Both vesicular and non - vesicular cholesterol transport occur in 185 steroidogenic cells , but non - vesicular transport involving high - 186 afﬁnity cholesterol - binding START - domain proteins appears to be 187 the principal means of cholesterol transport from lipid droplets 188 to mitochondria ( Miller and Bose , 2011 ) . START - domain proteins 189 are found in fungi , plants and animals ; the mammalian START - 190 domain proteins are termed StarD1 - 15 ( Clark , 2012 ) . The START 191 proteins most closely related to StAR ( StarD4 , D5 and D6 ) , bind 192 cholesterol and are induced by SREBP . StarD4 , D5 , and D6 lack 193 N - terminal signal sequences , suggesting they are cytosolic 194 proteins . StarD1 ( StAR ) , StarD3 ( MLN64 ) , StarD4 and StarD5 bind 195 cholesterol with high afﬁnity and speciﬁcity , facilitate cholesterol 196 transport through an aqueous environment , and appear to play 197 important roles in cellular cholesterol homeostasis ( Rodriguez - 198 Agudo et al . , 2008 ) . StAR and StarD6 stimulate the movement of 199 cholesterol from the OMM to the inner mitochondrial membrane 200 ( IMM ) , but StarD4 and StarD5 do not ( Bose et al . , 2008a ) . StarD4 201 and / or StarD5 may bring cholesterol to the OMM ; however , StarD4 202 knockout mice have no changes in steroidogenesis and minimal 203 changes in weight and serum lipids , hence an essential function 204 of StarD4 is not established ( Riegelhaupt et al . , 2010 ) . While all 205 the mechanisms that move cholesterol to the mitochondria have 206 not been determined , the current view is that the principal mech - 207 anism is by non - vesicular transport via StarD proteins , but that 208 StAR itself plays a minor role in this step . The OMM of adrenal 209 mitochondria contains abundant cholesterol , while the IMM con - 210 tains little cholesterol . Whether or not all OMM cholesterol is 211 potentially available for steroidogenesis has been unclear . Early 212 studies identiﬁed a distinct pool of ‘‘steroidogenic’’ OMM choles - 213 terol that was distinct from the structural membrane cholesterol 214 and could be mobilized by cAMP ( Stevens et al . , 1992 ) . Movement 215 of cholesterol from the OMM to the IMM is central to the initiation 216 of steroidogenesis , because the cholesterol side - chain cleavage en - 217 zyme ( P450scc ) system is localized to the IMM . Whether or nor 218 there are two kinetically distinct pools of cholesterol in the 219 OMM , and how cholesterol is transferred to the IMM remain under 220 investigation . 221 3 . Entry of cholesterol into steroidogenic mitochondria : action 222 of the steroidogenic acute regulatory protein , StAR 223 3 . 1 . Acute and chronic regulation of steroidogenesis 224 Unlike cells that produce polypeptide hormones , which store 225 large amounts of mature hormone available for rapid release , cells 226 that produce steroid homones store very little steroid , so that ste - 227 roid secretion requires induction of steroid synthesis . There are sev - 228 eral distinct mechanisms regulating steroidogenesis . In the adrenal , 229 ACTHpromotessteroidogenesisatthreelevels . First , overthecourse 230 of monthsACTH promotes adrenal growthvia ﬁbroblastgrowthfac - 231 tor , epidermal growth factor , insulin - like growth factor 2 , and pos - 232 sibly other factors . Second , over the course of days , ACTH , acting via 233 cAMP in the adrenal zona fasciculata and angiotensin II acting via 234 calcium / calmodulin in the zona reticularis promote transcription 235 of genes for steroidogenic enzymes , especially the gene encoding 236 P450scc ( CYP11A1 ) thus increasing the amounts of steroidogenic 237 enzymes . Third , acting on a 15 - 60 min time scale , ACTH rapidly 238 stimulates both the activation of pre - existing StAR and the synthe - 239 sis of new StAR . ACTH / cAMP stimulates phosphorylation of StAR at 240 Ser195 almost immediately , doubling its activity ( Arakane et al . , 241 1997 ) , and induces StAR transcription within minutes ( Jo et al . , 242 2005 ; Manna et al . , 2009 ) . StAR then interacts with a complex mac - 243 romolecular machine on the OMM to increase the ﬂow of choles - 244 terol from the OMM to the IMM where it becomes the substrate 245 for P450scc . The ﬁrst two modes of steroid regulation comprise 246 the chronic steroidogenic response and the action of StAR comprises 247 the acute steroidogenic response . 248 3 . 2 . The steroidogenic acute regulatory protein , StAR 249 StAR was discovered in the search for the factor that triggers the 250 acute steroidogenic response . Autoradiographic spots were noted 251 on 2 - dimentional gels that appeared within 30 min of stimulating 252 steroidogenic tissues ( Pon and Orme - Johnson , 1986 ; Pon et al . , 253 1986 ; Epstein and Orme - Johnson , 1991 ; Stocco and Sodeman W . L . Miller / Molecular and Cellular Endocrinology xxx ( 2013 ) xxx – xxx 3 MCE 8497 No . of Pages 11 , Model 5G 4 May 2013 Please cite this article in press as : Miller , W . L . Steroid hormone synthesis in mitochondria . Molecular and Cellular Endocrinology ( 2013 ) , http : / / dx . doi . org / 10 . 1016 / j . mce . 2013 . 04 . 014 254 1991 ) ; the cDNA was then cloned ( Clark et al . , 1994 ; Sugawara 255 et al . , 1995 ) , and the factor was named the steroidogenic acute reg - 256 ulatory protein , StAR ( reviewed in Stocco and Clark , 1996 ) . StAR is 257 a 37 - kDa protein with an N - terminal mitochondrial targeting se - 258 quence that is cleaved off during mitochondrial import to yield 259 30 - kDa intramitochondrial StAR . Co - expression of StAR and 260 P450scc in nonsteroidogenic cells rapidly increases conversion of 261 cholesterol to pregnenolone , suggesting that StAR triggers the 262 acute steroidogenic response ( Stocco and Clark , 1996 ) . The indis - 263 pensible role of StAR was demonstrated by ﬁnding that StAR muta - 264 tions cause congenital lipoid adrenal hyperplasia , in which very 265 little steroid is made ( Lin et al . , 1995 ; Bose et al . , 1996 ) . However , 266 some steroidogenesis can take place in the absence of StAR . In vivo , 267 the human placenta synthesizes steroids via mitochondrial 268 P450scc but does not express StAR ( Bose et al , 2000 ) . In vitro , cells 269 expressing the P450scc enzyme system but not StAR can convert 270 cholesterol to pregnenolone ( Harikrishna et al . , 1993 ; Black et al . , 271 1994 ) at (cid:2) 14 % of the maximal StAR - induced rate ( Lin et al . , 272 1995 ; Bose et al . , 1996 ) . StAR - independent steroidogenesis might 273 occur without a triggering protein , possibly using intracellular 274 hydroxysterols that bypass StAR action ; alternatively , another pro - 275 tein , such as the 30 kDa proteolytic cleavage product of MLN64 , 276 may exert StAR - like activity to promote mitochondrial cholesterol 277 import , but the precise mechanism ( s ) are unclear . 278 3 . 3 . StAR acts on the outer mitochondrial membrane 279 The presence of a typical mitochondrial ‘leader’ sequence ini - 280 tially suggested that 37 kDa cytoplasmic StAR is a ‘precursor . and 281 that the 30 kDa intramitochondrial protein is the ‘mature form’ , 282 but these terms do not describe the biology of StAR ( Miller , 2007 ) . 283 The crystallographic structure of the START domain of MLN64 ( N - 284 216 MLN64 ) , which shares 37 % amino acid sequence identity with 285 StAR , suggested that 30 - kDa StAR acts in the intramembranous 286 space ( IMS ) to shuttle cholesterol from the OMM to the IMM ( Tsuj - 287 ishita and Hurley , 2000 ) . This structure shows a globular protein 288 with an a / b helix - grip fold and an elongated hydrophobic pocket 289 approximately 26 Å deep and 10 Å across at its widest diameter . 290 The structure of StAR was then mod Q5 eled based on MLN64 ( Mathieu 291 et al . , 2002 ; Yaworsky et al . , 2005 ) and these models have been con - 292 ﬁrmed by crystallography at 3 . 4 Å resolution ( Thorsell et al . , 2011 ) . 293 The sterol - binding pocket of StAR accommodates a single molecule 294 of cholesterol with its 3 b - OH group coordinated by the two polar 295 residues . These structures and the structureof StarD4 ( Romanowski 296 et al . , 2002 ) are characterized by long N - and C - terminal a - helixes , 297 two short a - helixes , and 9 antiparallel b sheets that form a helix - 298 grip fold . However , deletion of StAR’s mitochondrial leader has no 299 effect on its activity ( Arakane et al . , 1996 ) , and both the 37 kDa 300 and30 kDaformsofStARareequallyactiveinvivoandinvitro ( Bose 301 et al . , 2002 ) . When StAR was fused to the cytoplasmic C - terminus of 302 the OMM protein Tom - 20 , thus immobilizing StAR an OMM , it was 303 constituitively active , but when StAR was immobilized in the IMS or 304 on the matrix side of the IMM , it was wholly inactive . Furthermore , 305 manipulating the speed of StAR’s mitochondrial entry by manipu - 306 lating the leader sequence showed that faster import decreased 307 activity whereas slower import increased activity ( Bose et al . , 308 2002 ) . Thus , StAR acts exclusively on the OMM and its activity is 309 proportional to how long it remains on the OMM . Thus it is the 310 OMMlocalizationof StAR , andnot its cleavagefromthe37 kDaform 311 to the 30 kDa form , that determines its activity . 312 3 . 4 . StAR’s action requires conformational changes and serine 313 phosphorylation 314 The mechanism by which StAR triggers cholesterol ﬂux from 315 the OMM to the IMM involves a multi - protein complex on the 316 OMM ( see below ) and requires pH - induced conformational 317 changes in StAR that are needed for StAR to accept and discharge 318 cholesterol ( Bose et al . , 1999 ; Baker et al . , 2005 ) . StAR can transfer 319 cholesterol between synthetic , protein - free membranes in vitro , 320 but with non - physiologic stoichiometry ( Tuckey et al . , 2002 ) , and 321 a biologically inactive StAR mutant ( R182L ) can also transfer cho - 322 lesterol to membranes in vitro ( Baker et al . , 2007 ) . Thus choles - 323 terol - binding is necessary but not sufﬁcient for StAR activity . 324 Proteolysis of StAR bound to synthetic membranes that model 325 OMM lipid composition showed that only the exterior surface of 326 the C - terminal a - helix and small segments of the adjacent X - loops 327 were protected , suggesting that only these domains interact with 328 the OMM ( Yaworsky et al . , 2005 ) . Molecular dynamics studies 329 show that cholesterol is blocked from reaching the cholesterol - 330 binding pocket of StAR by a set of hydrogen bonds that are dis - 331 rupted when the surface residues of StAR are protonated ( as hap - 332 pens when StAR interacts with charged phospholipids on the 333 OMM ) , thus eliciting a conformational change that permits choles - 334 terol access ( Bose et al . , 1999 ; Baker et al . , 2005 ) . When the move - 335 ment of the C - helix is prohibited by mutagenesis that creates 336 disulﬁde bonds , activity is lost , but reducing these bonds restores 337 activity , showing that the immobilized C - helix , and not the muta - 338 genesis , is responsible for the lost activity ( Baker et al . , 2005 ) . Thus 339 the activity of StAR on the OMM requires an acid - induced disrup - 340 tion of hydrogen bonds and a consequent conformational change 341 in StAR to permit it to bind and release cholesterol . 342 The phosphorylation of StAR on Ser 195 approximately doubles 343 StAR’s activity ( Arakane et al . , 1997 ) . It appars that the protein ki - 344 nase A ( PKA ) anchor protein AKAP121 recruits the type II PKA reg - 345 ulatory subunit a ( PKAR2A ) to the OMM , which phosphorylates 346 StAR , whereas the type I kinase drives StAR transcription ( Dyson 347 et al . , 2009 ) . A physical interaction between the 37 kDa cytoplas - 348 mic form of StAR and HSL has also been reported ( Shen et al . , 349 2003 ) . StAR is recycled , with each molecule moving hundreds of 350 molecules of cholesterol into the mitochondria before StAR is im - 351 ported into the mitochondria and is inactivated ( Artemenko 352 et al . , 2001 ) . 353 4 . StAR interacts with an OMM protein complex 354 4 . 1 . The peripheral benzodiazepine receptor or mitochondrial 355 transporter protein 356 StAR acts on the OMM via a complex that consists of several 357 proteins , most of which are now identiﬁed , even though it remains 358 unclear what role each plays in the mitochondrial importation of 359 cholesterol ( Bose et al . , 2008b ; Rone et al . , 2012 ; Papadopoulos 360 and Miller , 2012 ) . The ﬁrst of these proteins to be identiﬁed is 361 the peripheral benzodiazepine receptor ( PBR ) ( Lacapere and 362 Papadopoulos , 2003 ) , now also called the mitochondrial 363 transporter protein ( TSPO ) ( Papadopoulos et al . , 2006 ) . It was ini - 364 tially proposed that PBR / TSPO was the ‘acute trigger’ of steroido - 365 genesis , but it is now clear that StAR plays that role , and that 366 PBR / TSPO is part of the molecular machine on the OMM through 367 which StAR acts ( Papadopoulos and Miller , 2012 ) . PBR / TSPO is a 368 ubiquitously expressed 18 kDa protein that comprises up to 2 % of 369 OMM protein . PBR / TSPO ligands can stimulate cholesterol move - 370 ment from the OMM to the IMM and stimulate steroidogenesis 371 ( Lacapere and Papadopoulos , 2003 ) . Knockdown of the gene 372 encoding PBR / TSPO in Leydig cells disrupts cholesterol transport 373 and steroidogenesis , and transfection of the PBR / TSPO - disrupted 374 cells with the wild - type cDNA rescues steroidogenesis ( Papadopo - 375 ulos et al . , 1997 ) . However , knocking out the PBR / TSPO gene in 376 mice caused early embryonic lethality , indicating its indispensible 377 role during development ( Lacapere and Papadopoulos , 2003 ) . 4 W . L . Miller / Molecular and Cellular Endocrinology xxx ( 2013 ) xxx – xxx MCE 8497 No . of Pages 11 , Model 5G 4 May 2013 Please cite this article in press as : Miller , W . L . Steroid hormone synthesis in mitochondria . Molecular and Cellular Endocrinology ( 2013 ) , http : / / dx . doi . org / 10 . 1016 / j . mce . 2013 . 04 . 014 378 As is typical of proteins associated with the OMM , PBR / TSPO 379 lacks a cannonical mitochondrial targeting sequence ; instead , the 380 C - terminal half targets PBR / TSPO to the OMM ( Rone et al . , 2009 ) . 381 PBR / TSPO appears to have ﬁve transmembrane a - helices spanning 382 the OMM ( Joseph - Liauzun et al . , 1998 ; Korkhov et al . , 2010 ) , sug - 383 gesting that TSPO functions as a cholesterol channel , consistent 384 with data indicating that PBR / TSPO acts downstream from StAR 385 ( Hauet et al . , 2005 ; Liu et al . , 2006 ) . PBR / TSPO and has a cytoplas - 386 mic domain containing a ‘‘cholesterol recognition amino acid con - 387 sensus’’ ( CRAC ) domain ( Li et al . , 2001 ) . PBR / TSPO binds cholesterol 388 at the CRAC domain , suggesting that this domain participates in 389 transferring cholesterol from the OMM to the IMM ( Jamin et al . , 390 2005 ) . Mutagenesis of the CRAC domain interferes with cholesterol 391 binding and transfer of cholesterol to the IMM , and blocking the 392 binding of cholesterol to the CRAC domain prevents steroidogene - 393 sis ( Midzak et al . , 2011 ) . Targeted deletion of the TSPO gene in an 394 immortalized Leydig cell line blocked cholesterol transport into the 395 mitochondria and reduced steroid production ; reintroduction of 396 TSPO into the deﬁcient cell line restored steroidogenic capacity 397 ( Li et al . , 2001 ) . 398 4 . 2 . Other components of the OMM protein complex 399 PBR / TSPO is a component of a 140 – 200 kDa multi - protein com - 400 plex consisting of PBR / TSPO , the 34 - kDa voltage - dependent anion 401 channel ( VDAC1 ) , the 30 - kDa the adenine nucleotide transporter 402 ( ANT ) , the 10 - kDa diazepam - binding inhibitor ( acyl - CoA - binding 403 domain 1 , ACBD1 ) , the TSPO - associated protein - 1 ( PRAX - 1 ) , and 404 the PKA regulatory subunit RI a - associated protein 7 ( PAP7 ) ( Rone 405 et al . , 2012 ) . PAP7 , also known as acyl - CoA binding domain - 406 containing protein 3 ( ACBD3 ) , binds both TSPO and the regulatory 407 subunit RI a of PKA ( Fan et al . , 2010 ) . PBR / TSPO interacts with 408 VDAC on the OMM , helping to anchor the multi - protein complex 409 to the OMM and assisting with the binding and import of StAR 410 ( Liu et al . , 2006 ) ; VDAC1 also interacts with ANT on the IMM ( McE - 411 nery et al . , 1992 ) . While a functional interaction between StAR and 412 PBR / TSPO is clear ( Hauet et al . , 2005 ) , a physical interaction has not 413 been demonstrated ; protein cross - linking experiments indicate 414 that StAR directly interacts with VDAC1 and with phosphate carrier 415 protein ( PCP ) , but not with PBR / TSPO ( Bose et al . , 2008b ) . VDAC1 416 also appears to interact with PBR / TSPO ( Liu et al . , 2006 ; Rone 417 et al . , 2009 ) . It is not clear how VDAC - 1 participates in cholesterol 418 import , as VDAC - 1 has a ring - like structure with a hydrophilic inte - 419 rior that is well - suited to anion transport , but is unlikely to form a 420 channel for hydrophobic cholesterol ( Bayrhuber et al . , 2008 ; Hiller 421 et al . , 2008 ) . VDAC is found at contact sites between the OMM and 422 the IMM ( Mannella et al . , 1992 ) where it may complex with hexo - 423 kinase , ANT , creatine kinase and proteins of the Bcl - 2 family 424 ( Brdiczka et al . , 2006 ) . 425 5 . Mutations in StAR – congenital lipoid adrenal hyperplasia 426 ( Lipoid CAH ) 427 Lipoid CAH is characterized by absent or very low serum 428 concentrations of all steroids , high basal ACTH and plasma renin 429 activity , and grossly enlarged adrenals ﬁlled with cholesterol and 430 cholesteryl esters ( Miller , 1997 ) . Lipoid CAH was initially thought 431 to be an enzymatic disorder and was mis - termed ‘20 , 22 - desmolase 432 deﬁciency’ , but the CYP11A1 gene for P450scc is not mutated in 433 these patients ( Lin et al . , 1991 ) , and the placenta ( a fetal tissue ) 434 continues to produce progesterone in lipoid CAH ( Saenger et al . , 435 1995 ) , indicating a lesion upstream from P450scc , such as in a fac - 436 tor involved in mitochondrial cholesterol transport ( Lin et al . , 437 1991 ) . Mutations in the gene for PBR / TSPO were sought and ex - 438 cluded ( Lin et al . , 1993 ) , but mutations were found in StAR ( Lin 439 et al . , 1995 ; Bose et al . , 1996 ) , so that lipoid CAH represents the 440 StAR knockout experiment of nature ( Miller , 1997 ) . 441 The pathophysiology of lipoid CAH is explained by the two - hit 442 model ( Bose et al . , 1996 ) . The ﬁrst hit is lost StAR activity , causing 443 diminished steroidogenesis and a compensatory rise in ACTH and 444 gonadotropins . These increased tropic hormones stimulate intra - 445 cellular cAMP production , increasing LDL receptors , LDL choles - 446 terol uptake , and de novo synthesis of cholesterol . Intracellular 447 cholesterol then accumulates , causing the second hit : the loss of 448 remaining steroidogenic capacity due to mitochondrial damage 449 from the accumulated cholesterol , cholesteryl esters , and their 450 auto - oxidation products ( Bose et al . , 1996 ) ( Fig . 2 ) . The absence 451 of StAR activity affects fetal testicular Leydig cells early in gesta - 452 tion , preventing synthesis of the testosterone needed for the devel - 453 opment of male external genitalia , hence affected 46 , XY fetuses are 454 born with female external genitalia . However , the testicular Sertoli 455 cells function normally and produce anti - Müllerian hormone , so 456 the phenotypically female 46 , XY fetus lacks female internal repro - 457 ductive organs . The fetal adrenal typically produces very little 458 aldosterone , so that the zona glomerulosa is not tropicly stimu - 459 lated and hence usually remains undamaged until after birth . 460 Hence , newborns with lipoid CAH may not have a salt - wasting 461 crisis until several months of life , when chronic stimulation then 462 leads to cellular damage . 463 The two - hit model has been conﬁrmed in clinical studies , 464 explaining why affected 46 , XX patients feminize at the age of pub - 465 erty ( Bose et al . , 1997 ; Fujieda et al . , 1997 ) , and also in knockout 466 mice ( Hasegawa et al . , 2000 ) . The fetal ovary makes essentially 467 no steroids and remains unstimulated and hence undamaged until 468 adolescence , when it is stimulated by pubertal gonadotropins , 469 yielding small amounts of estrogen produced by StAR - independent 470 steroidogenesis . However , this low level of steroidogenesis is insuf - 471 ﬁcient to generate progesterone in response to the mid - cycle LH 472 surge ; continued stimulation results in cholesterol accumulation 473 and cellular damage , impairing the later biosynthesis of progester - 474 one , resulting in anovulatory cycles . Gonadotropin stimulation 475 does not promote global ovarian steroidogenesis , but only recruits 476 individual follicles , hence most follicles remain undamaged and 477 available for future cycles . A new follicle is recruited with each 478 successive cycle , producing estradiol by StAR - independent steroi - 479 dogenesis , resulting in breast development , so that the patient 480 experiences general feminization , monthly estrogen withdrawal 481 and cyclic vaginal bleeding . 482 Lipoid CAH is relatively common in Japan and Korea , where the 483 carrier frequency is approximately one in 300 , and most affected 484 individuals carry the mutation Q258X ( Bose et al . , 1996 ; Nakae 485 et al . , 1997 ; Kim et al . , 2011 ) . Mutations retaining about 10 – 25 % 486 of normal StAR activity , especially R188C , cause a milder disease 487 called ‘‘non - classic lipoid CAH’’ , characterized by adrenal insufﬁ - 488 ciency several years after infancy , nearly normal masculinization 489 of 46 , XY individuals , and minimally affected mineralocorticoid 490 secretion ( Baker et al . , 2006 ) . 491 6 . Thecholesterol side chain cleavage enzyme – the prototypical 492 mitochondrial P450 493 6 . 1 . Cytochrome P450 enzymes 494 Once cholesterol reaches the IMM , it may be converted to 495 pregnenolone to initiate steroidogenesis . Most steroidogenic 496 enzymes are cytochrome P450 enzymes , all of which have approx - 497 imately 500 residues , contain a single heme group and absorb light 498 at 450 nm when reduced with carbon monoxide . The human gen - 499 ome contains 57 CYP genes encoding cytochrome P450 enzymes ; 500 the corresponding proteins may be given the same name without W . L . Miller / Molecular and Cellular Endocrinology xxx ( 2013 ) xxx – xxx 5 MCE 8497 No . of Pages 11 , Model 5G 4 May 2013 Please cite this article in press as : Miller , W . L . Steroid hormone synthesis in mitochondria . Molecular and Cellular Endocrinology ( 2013 ) , http : / / dx . doi . org / 10 . 1016 / j . mce . 2013 . 04 . 014 501 the use of italics ( thus CYP11A1 encodes the cholesterol side chain 502 cleavage enzyme , P450scc ; which may also be termed CYP11A1 , 503 without italics ) . Seven human cytochrome P450 enzymes are tar - 504 geted to the mitochondria , the other 50 are targeted to the ER ; 505 the roles of the human P450 enzymes have been reviewed recently 506 ( Nebert et al . , 2013 ) . P450 enzymes activate molecular oxygen via 507 their heme iron using electrons donated by nicotinamide adenine 508 dinucleotide phosphate ( NADPH ) . Mitochondrial ( type 1 ) P450 en - 509 zymes receive electrons from NADPH via an electron transfer chain 510 consisting of a ﬂavoprotein termed ferredoxin reductase and a 511 small iron - sulfur protein termed ferredoxin ( Miller , 2005 ) 512 ( Fig . 3 ) . The type 2 P450 enzymes in the ER receive electrons via 513 a single 2 - ﬂavin protein termed P450 oxidoreductase ( Miller , 514 2005 ) . All P450 enzymes can catalyze multiple chemical reactions , 515 often with very different substrates . 516 6 . 2 . Steps in steroidogenesis 517 Six P450 enzymes participate in steroidogenesis , and at least 518 three more participate in the processing of vitamin D ; ﬁve of these 519 are found in mitochondria . Steroidogenesis is initiated by mito - 520 chondrial P450scc . P450scc cleaves the 20 , 22 bond of insoluble 521 cholesterol to produce soluble pregnenolone , and is the hormon - 522 ally regulated , rate - limiting step in steroidogenesis . It is the 523 expression of the CYP11A1 gene that renders a cell ‘steroidogenic’ . 524 Pregnenolone may then be converted to progesterone by 3 b - 525 hydroxysteroid dehydrogenase ( 3 b HSD ) , which may be found both 526 in the mitochondria and in the ER ( see Section 9 ) . Alternatively , 527 pregnenolone may exit the mitochondrion and become the sub - 528 strate for P450c17 in the ER , which catalyzes both 17 a - hydroxy - 529 lase and 17 , 20 lyase activities . Pregnenolone appears to exit the 530 mitochondrion unaided ; no transport protein has been found , 531 and physiologic evidence does not suggest the presence of such a 532 transporter . Following the activities of 3 b HSD and P450c17 , Fig . 2 . Two - hit model of lipoid CAH . ( A ) In normal adrenal cells , cholesterol is primarily derived from low - density lipoproteins , and the rate - limiting step in steroidogenesis is movement of cholesterol from the OMM to the IMM . ( B ) Early in lipoid CAH , StAR - independent steroidogenesis moves small amounts of cholesterol into mitochondria , yielding sub - normal steroidogenesis ; ACTH secretion increases , stimulating further accumulation of cholesteryl esters in lipid droplets . ( C ) As lipids accumulate , they damage the cell through physical engorgement and by the action of cholesterol auto - oxidation products ; steroidogenic capacity is destroyed , but tropic stimulation continues . Ovarian follicular cells remain unstimulated and undamaged until puberty , when small amounts of estradiol are produced , as in B , causing phenotypic feminization , with infertility and hypergonadotropic hypogonadism . Modiﬁed from ( Bose et al . , 1996 ) , with permission . Fig . 3 . Organization of mitochondrial P450 enzyme systems . NADPH ﬁrst donates electrons to the FAD moiety of ferredoxin reductase ( FeRed ) ; ferredoxin reductase then interacts with ferredoxin ( Fedx ) by charge - charge attraction , permitting electron transfer of the Fedx to the Fe 2 S 2 center ( ball and stick diagram ) . Ferredoxin then dissociates from ferredoxin reductase and diffuses through the mitochrondrial matrix . The same surface of ferredoxin that received the electrons from ferredoxin reductase then interacts with the redox - partner binding - site of a mitochondrial P450 , such as P450scc , and the electrons then travel to the heme ring of the P450 . The heme iron then mediates catalysis with substrate bound to the P450 . (cid:2) WL Miller . 6 W . L . Miller / Molecular and Cellular Endocrinology xxx ( 2013 ) xxx – xxx MCE 8497 No . of Pages 11 , Model 5G 4 May 2013 Please cite this article in press as : Miller , W . L . Steroid hormone synthesis in mitochondria . Molecular and Cellular Endocrinology ( 2013 ) , http : / / dx . doi . org / 10 . 1016 / j . mce . 2013 . 04 . 014 533 P450c21 catalyzes the 21 - hydroxylation of both glucocorticoids 534 and mineralocorticoids . The ﬁnal steps in the synthesis of both glu - 535 cocorticoids and mineralocorticoids again takes place in the mito - 536 chondria , where two proteins that share 93 % sequence identity , 537 11 b - hydroxylase ( P450c11 b , CYP11B1 ) , and aldosterone synthase 538 ( P450c11AS , CYP11B2 ) reside . P450c11 b catalyzes the 11 b - hydrox - 539 ylation of 11 - deoxycortisol to cortisol , and P450c11AS catalyzes 540 the 11 b - hydroxylation , 18 - hydroxylation , and 18 - methyl oxidation 541 to convert deoxycorticosterone to aldosterone . Histologic and elec - 542 tron microscopic examination of steroidogenic cells suggests that 543 domains of the ER containing the steroidogenic P450 enzymes 544 come close to the OMM during hormonally - induced steroidogene - 545 sis , forming a steroidogenic complex , so that the movement of ste - 546 roidal intermediates from the mitochondrion to the ER involves 547 very small distances . 548 6 . 3 . Chemistry and transcription of P450scc 549 P450scc catalyzes three reactions : 22 - hydroxylation of 550 cholesterol , 20 - hydroxylation of 22 ( R ) - hydroxycholesterol , and 551 oxidative scission of the C20 - 22 bond of 20 ( R ) , 22 ( R ) - dihydroxy - 552 cholesterol , yielding pregnenolone and isocaproaldehyde . The 553 binding of cholesterol and 22 - hydroxylation are rate - limiting , as 554 the efﬁciencies ( k cat / Km ) are much higher for the subsequent 555 reactions , and the high K D of (cid:2) 3000 nM drives the dissociation of 556 pregnenolone from P450scc ( Miller and Auchus , 2011 ) . Alterna - 557 tively , soluble hydroxysterols such as 22 ( R ) - hydroxycholesterol 558 can enter the mitochondrion readily , without the action of StAR 559 and its associated machinery . Catalysis by P450scc is slow , with 560 a net turnover of approximately 6 – 20 molecules of cholesterol 561 per molecule of P450scc per second . The crystal structures of 562 bovine ( Mast et al . , 2011 ) and human ( Strushkevich et al . , 2011 ) 563 P450scc , the latter in complex with ferredoxin , show that the sin - 564 gle active site of P450scc is in contact with the IMM . 565 Transcription of the CYP11A1 gene determines cellular steroido - 566 genic capacity . This transcription is regulated by hormonally - 567 responsive factors that differ in different types of steroidogenic 568 cells ; both the PKA and PKC second messenger systems can induce 569 CYP11A1 transcription via different promoter elements . Adrenal 570 and gonadal transcription of P450scc and other steroidogenic 571 enzymes requires the action of steroidogenic factor 1 ( SF1 ) 572 ( Schimmer and White , 2010 ) . By contrast , placental expression of 573 P450scc is constitutive , independent of SF1 and requires members 574 of the CP2 ( graineyhead ) family of transcription factors ( also known 575 as LBP proteins ) ( Huang and Miller , 2000 ; Henderson et al . , 2007 ) 576 and TreP - 132 ( Gizard et al . , 2002 ) . Thus , long - term cellular stimu - 577 lation over the course of days will increase the content of P450scc , 578 and the level of basal steroid produced , as well as the capacity of 579 the cell to mount a steroidogenic response . 580 7 . Electron transfer to P450scc : ferredoxin reductase and 581 ferredoxin 582 7 . 1 . Ferredoxin reductase 583 Catalysis by P450scc and other mitochondrial P450 enzymes 584 requires two electron - transfer intermediates , ferredoxin reductase 585 and ferredoxin ( Miller , 2005 ) . Ferredoxin reductase receives elec - 586 trons from NADPH then forms a 1 : 1 complex with ferredoxin , 587 which then dissociates and forms an analogous 1 : 1 complex with 588 a mitochondrial P450 such as P450scc , thus functioning as an 589 indiscriminate , diffusible electron shuttle for all mitochondrial 590 forms of P450 ( Fig . 3 ) . The relative abundances of ferredoxin reduc - 591 tase and ferredoxin , as well as the inherent properties of the mito - 592 chondrial P450 , determine catalytic activity ( Harikrishna et al . , 593 1993 ) . Genetic disorders of human ferredoxin reductase and ferre - 594 doxin have not been described , and mouse knockouts have not 595 been reported . Mutation of the Drosophila ferredoxin reductase 596 homologue dare causes developmental arrest and degeneration of 597 the adult nervous system secondary to disrupted ecdysone produc - 598 tion ( Freeman et al . , 1999 ) . 599 The human FDXR gene produces two alternatively spliced ferre - 600 doxin reductase mRNAs differing by 18 bp ( Solish et al . , 1988 ) , but 601 only the protein encoded by the more abundant , shorter mRNA is 602 active ( Brandt and Vickery , 1992 ) . Ferredoxin reductase mRNA is 603 widely expressed , but is far more abundant in steroidogenic tissues 604 ( Brentano et al , 1992 ) . Ferredoxin reductase is a 54 . 5 kDa ﬂavopro - 605 tein afﬁxed to the IMM that consists of two domains , each 606 comprising a b - sheet core surrounded by a - helices ( Ziegler et al . , 607 1999 ) . The NADP ( H ) - binding domain is compact , whereas the 608 domain that binds ﬂavin adenine dinucleotide ( FAD ) is more open ; 609 this domain binds the dinucleotide portion of FAD across a 610 Rossman fold with the redox - active ﬂavin isoalloxazine ring abut - 611 ting the NADP ( H ) domain . Electron transfer occurs in the cleft 612 formed by these two domains . This cleft is characterized by basic 613 residues that interact with acidic residues on ferredoxin . 614 7 . 2 . Ferredoxin 615 The human FDX1 gene encodes ferredoxin ( Fdx1 ) , a 14 kDa , 616 soluble , iron / sulfur ( Fe 2 S 2 ) protein that resides either free in the 617 mitochondrial matrix or is loosely bound to the inner mitochon - 618 drial membrane ( Miller , 2005 ) . There are two human ferredoxins , 619 Fdx1 and Fdx2 , but only Fdx1 supports steroidogenic mitochon - 620 drial P450 enzymes ; Fdx2 participates in the synthesis of heme 621 and Fe / S cluster proteins ( Sheftel et al . , 2010 ) . Ferredoxin has a 622 core region containing four cysteine residues that tether the 623 Fe 2 S 2 cluster , and an interaction domain containing a helix with 624 several charged residues , producing a negatively charged surface 625 above the Fe 2 S 2 cluster that interacts with the mitochondrial 626 P450 ( Muller et al . , 1998 ) . 627 7 . 3 . Mitochondrial P450 fusion proteins 628 The same surface of ferredoxin interacts with both ferredoxin 629 reductase and the P450 ; nevertheless , creation of three - component 630 fusion proteins of the general scheme H 2 N - P450 - FerredoxinReduc - 631 tase - Ferredoxin - COOH ( termed F2 ) increases Vmax . This design 632 was ﬁrst tested with P450scc ( Harikrishna et al . , 1993 ) and has 633 been conﬁrmed with P450c27 ( Dilworth et al . , 1996 ) and 634 P450c11 b ( Cao et al . , 2000 ) . In such fusions , the ferredoxin moiety 635 is at the C - terminus , tethered by a hydrophilic linker that permits 636 rotational freedom , so that the same surface of the ferredoxin can 637 access both the P450 and the ferredoxin reductase . The require - 638 ment for ferredoxin reductase and ferredoxin is not absolute , at 639 least in vitro . When P450scc is fused to an alternative electron 640 donor , microsomal P450 oxidoreductase and targeted of to the 641 mitochondria , it remains active ; by contrast when P450scc , its 642 fusion protein , or other P450scc constructs are targeted to the 643 ER , they are inactive even when supplied with the 22 ( R ) - hydroxy - 644 cholesterol substrate that bypasses the StAR system ( Black et al . , 645 1994 ) . Thus the mitochondrial localiztion is essential for the enzy - 646 matic activity of P450scc . 647 8 . P450scc deﬁciency syndromes 648 Three models of defective P450scc function , a spontaneously 649 occurring CYP11A1 deletion in the rabbit ( Yang et al . , 1993 ) , knock - 650 out of the gene in the mouse ( Hu et al . , 2002 ) , and rare patients 651 with P450scc mutations conﬁrm that P450scc is the only enzyme W . L . Miller / Molecular and Cellular Endocrinology xxx ( 2013 ) xxx – xxx 7 MCE 8497 No . of Pages 11 , Model 5G 4 May 2013 Please cite this article in press as : Miller , W . L . Steroid hormone synthesis in mitochondria . Molecular and Cellular Endocrinology ( 2013 ) , http : / / dx . doi . org / 10 . 1016 / j . mce . 2013 . 04 . 014 652 that converts cholesterol to pregnenolone . Because progesterone is 653 needed to suppress uterine contractility and thus prevent sponta - 654 neous abortion , it would appear that P450scc mutations would be 655 incompatible with term gestation ; the mouse and rabbit models 656 are explained by the persistence of the maternal corpus luteum 657 in these species , providing an alternative source of progesterone . 658 Nevertheless , beginning in 2001 ( Tajima et al . , 2001 ) 19 patients 659 have been described with mutations in CYP11A1 that affect 660 P450scc activity ( Tee et al . , 2013 ) . Most of these patients have 661 mutations that ablate all P450scc activity ; they probably reached 662 term gestation because of the maternal corpus luteum remained 663 functional beyond the second trimester , when it normally invo - 664 lutes . These patients may be clinically indistinguishable from those 665 with lipoid CAH . The 46 , XY genetic males fail to produce testoster - 666 one during fetal life , and are born with female external genitalia , 667 although their internal reproductive structures are male , as their 668 testes produced anti - Müllerian hormone . Following birth , these 669 patients require steroid hormone replacement therapy and may 670 have long - term survival . As with non - classical lipoid CAH , a milder 671 ‘‘non - classical’’ form of P450scc deﬁciency has been described 672 caused by missense mutations that retain 10 – 20 % of normal 673 activity ( Rubtsov et al . , 2009 ; Sahakitrungruang et al . , 2011 ) . No 674 hormonal test distinguishes lipoid CAH from P450scc deﬁciency , 675 but the adrenals are typically grossly enlarged in lipoid CAH but 676 normal - sized in P450scc deﬁciency , sometimes permitting radio - 677 logic distinction , but the only deﬁnitive test to distinguish these 678 disorders is DNA sequencing ( Gucev et al . , 2013 ) . 679 9 . 3 b - hydroxysteroid dehydrogenase 680 The 42 kDa 3 b - hydroxysteroid dehydrogenase ( 3 b HSD ) is a 681 member of the short - chain dehydrogenase / reductase ( SDR ) family 682 of enzymes , which are are b - a - b proteins having up to seven par - 683 allel b - strands that fan across the center of the molecule , forming 684 the so - called ‘‘Rossman fold’’ , which is characteristic of oxida - 685 tion / reduction enzymes that use nicotinamide cofactors ( Agarwal 686 and Auchus , 2005 ; Penning , 1997 ) . 3 b HSD converts D 5 steroids 687 ( pregnenolone , 17OH - pregneneolone , DHEA ) , having a double 688 bond in the B ring to D 4 steroids , having a double bond in the A 689 ring ( Miller and Auchus , 2011 ) . Members of this family of enzymes 690 lack mitochondrial leader peptides and are generally found in the 691 cytosol . However , 3 b HSD was ﬁrst isolated from mitochondria 692 ( Thomas et al . , 1989 ) . This unexpected cellular localization was 693 conﬁrmed by immunogold electron microscopy showing that 694 3 b HSD immunoreactivity is found in mitochondria and endoplas - 695 mic reticulum as well as in the cytoplasm of bovine adrenal zona 696 glomerulosa cells ( Cherradi et al . , 1997 ; Pelletier et al . , 2001 ) . It 697 is not clear if this is also true for human 3 b HSD , or if this subcellu - 698 lar distribution differs in various types of steroidogenic cells , but 699 this property could be a novel mechanism for regulating the direc - 700 tion of steroidogenesis . 3 b HSD appears to be associated with 701 P450scc on the IMM , and possibly at OMM - IMM contact sites 702 ( Cherradi et al . , 1995 ) . 3 b HSD and 17 a - hydroxylase ( P450c17 ) 703 compete for the pregnenolone produced by P450scc . The Michaelis 704 constant ( Km ) for P450c17 in the ER is about 0 . 8 l M ( Auchus et al . , 705 1998 ) , whereas the Km of 3 b HSD is about 5 . 2 – 5 . 5 l M ( Lee et al . , 706 1999 ) , so that an intramitochondrial location of 3 b HSD will facili - 707 tate the formation of progesterone rather than 17OH - pregneno - 708 lone . During its mitochondrial entry , 3 b HSD associates with 709 several mitochondrial translocase proteins to reach the IMM ( Paw - 710 lak et al . , 2011 ) and undergoes a pH - dependent conformational 711 change in the intramembranous space that facilitates its two enzy - 712 matic activities ( Prasad et al . , 2012 ) . 713 There are two 3 b HSD genes and several pseudogenes in a gene 714 cluster on chromosome 1p13 . 1 . The two encoded 3 b HSD enzymes 715 are 93 . 5 % identical with nearly indistinguishable enzymology , but 716 with distinct distributions of expression . The type 1 enzyme cata - 717 lyzes 3 b HSD activity in placenta , breast , liver , brain and some other 718 tissues , whereas the type 2 enzyme is expressd in the adrenals and 719 gonads . Deﬁciency of 3 b HSD2 causes a rare form of congenital 720 adrenal hyperplasia ( 3 b HSD deﬁciency ) ; mutations have not been 721 found in 3 b HSD1 , possibly reﬂecting the impact of such a mutation 722 on plcental progesterone synthesis . 723 10 . Other steroidogenic mitochondrial P450 enzymes 724 Adrenocortical mitochondria contain two additional P450 725 enzymes : P450c11 b ( 11 b - hydroxylase ) is found in zona fasciculata 726 cells where it catalyzes the conversion of 11 - deoxycortisol to cor - 727 tisol ; P450c11AS ( aldosterone synthase ) is found in zona glomerul - 728 osa cells where it catalyzes the three distinct reactions needed to 729 convert deoxycorticosterone to aldosterone ( White et al . , 1994 ; 730 Fardella and Miller , 1996 ; Miller and Auchus , 2011 ) . These two 731 proteins share 93 % amino acid sequence identity and are encoded 732 by duplicated genes termed CYP11B1 ( producing P450c11 b ) and 733 CYP11B2 ( producing P450c11AS ) . Like P450scc , both proteins have 734 typical mitochondrial targeting sequence and are associated with 735 the IMM . These enzymes must compete with P450scc for reducing 736 equivalents provided via ferredoxin reductase and ferredoxin . 737 Mutations in CYP11B1 cause 11 b - hydroxylase deﬁciency , a rare 738 form of virilizing congenital adrenal hyperplasia in which the over - 739 production of deoxycorticosterone may lead to mineralocorticoid 740 hypertension . Mutations in CYP11B2 cause aldosterone synthase 741 deﬁciency . An unusual recombination between the CYP11B1 and 742 CYP11B2 genes can place the CYP11B1 promoter upstream from 743 the CYP11B2 gene , thus producing aldosterone synthase in 744 response to ACTH , causing glucocorticoid suppressible 745 hyperaldosteronism . 746 11 . Mitochondrial P450 enzymes in vitamin D synthesis 747 Vitamin D and its metabolites are not steroids in the strict 748 chemical sense , as the B ring of cholesterol is opened ( Fig . 4 ) . Nev - 749 ertheless , these sterols are derived from cholesterol , assume 750 shapes that are very similar to steroids , and bind to a similar , 751 zinc - ﬁnger receptor that regulates gene transcription ( Feldman 752 et al . , 2013 ) . The ﬁnal step in the biosynthesis of cholesterol is 753 conversion of 7 - dehydrocholesterol to cholesterol . In human skin , 754 ultraviolet radiation at 270 – 290 nm directly cleaves the 9 – 10 car - 755 bon – carbon bond of the cholesterol B ring , converting 7 - dehydro - 756 cholesterol to cholecalciferol ( vitamin D 3 ) ( Norman , 1998 ) . Plants 757 produce ergocalciferol ( vitamin D 2 ) , which has essentially the same 758 properties as cholecalciferol . Both calciferols are biologically inac - 759 tive pro - hormones that are then activated , and subsequently inac - 760 tivated , by mitochondrial P450 enzymes . 761 The initial step in the activation of vitamin D is its hepatic 762 25 - hydroxylation to 25 ( OH ) D , which may be catalyzed by several 763 enzymes . The principal 25 - hydroxylase is CYP2R1 ( Cheng et al . , 764 2003 ) , and deﬁciency of this enzyme causes the very rare 765 25 - hydroxylase deﬁciency syndrome ( Cheng et al . , 2004 ; Dong 766 and Miller , 2004 ) . A hepatic mitochondrial P450 ( variously termed 767 P450c25 and P450c27 ) encoded by the CYP27A1 gene also has vita - 768 min D 25 - hydroxylase activity , but its mutation causes cerebroten - 769 dinous xanthomatosis without a disorder in calcium metabolism 770 ( Cali et al . , 1991 ; Leitersdorf et al . , 1993 ) , hence this mitochondrial 771 enzyme is of marginal importance to vitamin D metabolism . 772 The active , hormonal form of vitamin D , 1 , 25 ( OH ) 2 D , is pro - 773 duced by the 1 a - hydroxylation of 25 ( OH ) D by the mitochondrial 774 1 a - hydroxylase , P450c1 a , encoded by the CYP27B1 gene ( Fu 775 et al . , 1997a , b ) . 1 , 25 ( OH ) 2 D in the circulation derives primarily 8 W . L . Miller / Molecular and Cellular Endocrinology xxx ( 2013 ) xxx – xxx MCE 8497 No . of Pages 11 , Model 5G 4 May 2013 Please cite this article in press as : Miller , W . L . Steroid hormone synthesis in mitochondria . Molecular and Cellular Endocrinology ( 2013 ) , http : / / dx . doi . org / 10 . 1016 / j . mce . 2013 . 04 . 014 776 from the kidney , but 1 a - hydroxylase activity is also found in kerat - 777 inocytes , macrophages , osteoblasts and placenta . 1 a - hydroxylation 778 is the rate - limiting step in the activation of vitamin D , and renal 779 enzyme activity is tightly regulated by parathyroid hormone 780 ( PTH ) , calcium , phosphorus , and 1 , 25 ( OH ) 2 D itself . The ﬁrst human 781 clone was obtained from human keratinocytes , but multiple stud - 782 ies , including ﬁnding mutations in a patient affected with renal 783 1 a - hydroxylase deﬁciency , proved that the same gene was ex - 784 pressed in kidney ( Fu et al . , 1997a ) . Mutations in this gene cause 785 the disorder variously termed ‘vitamin D - dependent rickets , Type 786 1’ , ‘pseudo vitamin D - deﬁcient rickets’ and ‘vitamin D 1 a - hydrox - 787 ylase deﬁciency’ ( Wang et al . , 1998 ; Kim et al . , 2007 ) . The single 788 CYP27B1 gene for 1 a - hydroxylase is only 5 kb long and has an 789 intron / exon organization that is very similar to that of other mito - 790 chondrial P450 enzymes , especially the mitochondrial cholesterol 791 side - chain cleavage enzyme , P450scc ( Fu et al . , 1997b ) . Thus , even 792 though the mitochondrial P450 enzymes retain only 30 – 40 % amino 793 acid sequence identity with each other , they all belong to a single 794 evolutionary lineage . More than 100 patients with CYP27B1 muta - 795 tions have been described ( Edouard et al 2011 ) . 796 1 , 25 ( OH ) 2 D may be inactivated by the principal hepatic drug - 797 metabolizing enzyme , microsomal CYP3A4 , or by its 24 - hydroxyl - 798 ation by vitamin D 24 - hydroxylase ( P450c24 ) , encoded by the 799 CYP24A1 gene ( Feldman et al . , 2013 ) . This mitochondrial enzyme 800 can catalyze the 24 - hydroxylation of 25 ( OH ) D to 24 , 25 ( OH ) 2 D and 801 of 1 , 25 ( OH ) 2 D to 1 , 24 , 25 ( OH ) 3 D , primarily in the kidney and intes - 802 tine , thus inactivating vitamin D ( Ohyama et al . , 1991 ; Chen et al . , 803 1993 ) . The expression of P450c24 is induced by 1 , 25 ( OH ) 2 D , provid - 804 ingadirectfeedbackmechanismtoautoregulatecirculatinglevelsof 805 1 , 25 ( OH ) 2 D ( Xieetal . , 2002 ) . ThecrystalstructureofratP450c24has 806 been determined , showing a classic cytochrome P450 fold with an 807 open conformation which would suggest that this enzyme might 808 bind multiple different substrates , nevertheless , like all other mito - 809 chondrial P450’s , P450c24 exhibits a narrow substrate speciﬁcity 810 ( Annalora et al . , 2010 ) . Rare mutations in P450c24 result in elevated 811 circulating concentrations of 1 , 25 ( OH ) 2 D , causing severe neonatal 812 hypercalcemia ( Schlingmann et al . , 2011 ; Dauber et al . , 2012 ) . 813 References 814 Agarwal , A . K . , Auchus , R . J . , 2005 . Cellular redox state regulates hydroxysteroid 815 dehydrogenase activity and intracellular hormone potency . Endocrinology 146 , 816 2531 – 2538 . 817 Alpy , F . , Tomasetto , C . , 2006 . MLN64 and MENTHO , two mediators of endosomal 818 cholesterol transport . Biochem . Soc . Trans . 34 , 343 – 345 . 819 Alpy , F . , Stoeckel , M . E . , Dierich , A . , Escola , J . M . , Wendling , C . , Chenard , M . P . , Vanier , 820 M . T . , Gruenberg , J . , Tomasetto , C . , Rio , M . C . , 2001 . The steroidogenic acute 821 regulatory protein homolog MLN64 , a late endosomal cholesterol - binding 822 protein . J . Biol . Chem . 276 , 4261 – 4269 . 823 Alpy , F . , Wendling , C . , Rio , M . C . , Tomasetto , C . , 2002 . MENTHO , a MLN64 homologue 824 devoid of the START domain . J . Biol . Chem . 277 , 50780 – 50787 . 825 Annalora , A . J . , Goodin , D . B . , Hong , W . X . , Zhang , Q . , Johnson , E . F . , Stout , C . D . , 2010 . 826 Crystal structure of CYP24A1 , a mitochondrial cytochrome P450 involved in 827 vitamin D metabolism . J . Mol . Biol . 396 , 441 – 451 . 828 Arakane , F . , Sugawara , T . , Nishino , H . , Liu , Z . , Holt , J . A . , Pain , D . , Stocco , D . M . , Miller , 829 W . L . , Strauss 3rd . , J . F . , 1996 . Steroidogenic acute regulatory protein ( StAR ) 830 retains activity in the absence of its mitochondrial import sequence : 831 implications for the mechanism of StAR action . Proc . Natl . Acad . Sci . USA 93 , 832 13731 – 13736 . 833 Arakane , F . , King , S . R . , Du , Y . , Kallen , C . B . , Walsh , L . P . , Watari , H . , Stocco , D . M . , 834 Strauss 3rd , J . F . , 1997 . Phosphorylation of steroidogenic acute regulatory 835 protein ( StAR ) modulates its steroidogenic activity . J . Biol . Chem . 272 , 32656 – 836 32662 . 837 Artemenko , I . P . , Zhao , D . , Hales , D . B . , Hales , K . H . , Jefcoate , C . R . , 2001 . Mitochondrial 838 processing of newly synthesized steroidogenic acute regulatory protein ( StAR ) , 839 but not total StAR , mediates cholesterol transfer to cytochrome P450 side chain 840 cleavage enzyme in adrenal cells . J . Biol . Chem . 276 , 46583 – 46596 . 841 Auchus , R . J . , Lee , T . C . , Miller , W . L . , 1998 . Cytochrome b5 augments the 17 , 20 lyase 842 activity of human P450c17 without direct electron transfer . J . Biol . Chem . 273 , 843 3158 – 3165 . 844 Baker , B . Y . , Yaworsky , D . C . , Miller , W . L . , 2005 . A pH - dependent molten globule 845 transition is required for activity of the steroidogenic acute regulatory protein , 846 StAR . J . Biol . Chem . 280 , 41753 – 41760 . 847 Baker , B . Y . , Lin , L . , Kim , C . J . , Raza , J . , Smith , C . P . , Miller , W . L . , Achermann , J . C . , 2006 . 848 Nonclassic congenital lipoid adrenal hyperplasia : a new disorder of the 849 steroidogenic acute regulatory protein with very late presentation and 850 normal male genitalia . J . Clin . Endocrinol . Metab . 91 , 4781 – 4785 . 851 Baker , B . Y . , Epand , R . F . , Epand , R . M . , Miller , W . L . , 2007 . Cholesterol binding does not 852 predict activity of the steroidogenic acute regulatory protein , StAR . J . Biol . 853 Chem . 282 , 10223 – 10232 . 854 Bayrhuber , M . , Meins , T . , Habeck , M . , Becker , S . , Giller , K . , Villinger , S . , Vonrhein , C . , 855 Griesinger , C . , Zweckstetter , M . , Zeth , K . , 2008 . Structure of the human voltage - 856 dependent anion channel . Proc . Natl . Acad . Sci . USA 105 , 15370 – 15375 . 857 Black , S . M . , Harikrishna , J . A . , Szklarz , G . D . , Miller , W . L . , 1994 . The mitochondrial 858 environment is required for activity of the cholesterol side - chain cleavage 859 enzyme , cytochrome P450scc . Proc . Natl . Acad . Sci . USA 91 , 7247 – 7251 . 860 Bose , H . S . , Sugawara , T . , Strauss 3rd , J . F . , Miller , W . L . , 1996 . The pathophysiology 861 and genetics of congenital lipoid adrenal hyperplasia . N . Engl . J . Med . 335 , 862 1870 – 1878 . 863 Bose , H . S . , Pescovitz , O . H . , Miller , W . L . , 1997 . Spontaneous feminization in a 46XX 864 female patient with congenital lipoid adrenal hyperplasia caused by a 865 homozygous frame - shift mutation in the steroidogenic acute regulatory 866 protein . J . Clin . Endocrinol . Metab . 82 , 1511 – 1515 . 867 Bose , H . S . , Whittal , R . M . , Baldwin , M . A . , Miller , W . L . , 1999 . The active form of the 868 steroidogenic acute regulatory protein , StAR , appears to be a molten globule . 869 Proc . Natl . Acad . Sci . USA 96 , 7250 – 7255 . 870 Bose , H . S . , Whittal , R . M . , Huang , M . C . , Baldwin , M . A . , Miller , W . L . , 2000 . N - 218 871 MLN64 , a protein with StAR - like steroidogenic activity , is folded and cleaved 872 similarly to StAR . Biochemistry 39 , 11722 – 11731 . 873 Bose , H . S . , Lingappa , V . R . , Miller , W . L . , 2002 . Rapid regulation of steroidogenesis by 874 mitochondrial protein import . Nature 417 , 87 – 91 . 875 Bose , H . S . , Whittal , R . M . , Ran , Y . , Bose , M . , Baker , B . Y . , Miller , W . L . , 2008a . StAR - like 876 activity and molten globule behavior of StARD6 , a male germ - line protein . 877 Biochemistry 47 , 2277 – 2288 . 878 Bose , M . , Whittal , R . M . , Miller , W . L . , Bose , H . S . , 2008b . Steroidogenic activity of StAR 879 requires contact with mitochondrial VDAC1 and phosphate carrier protein . J . 880 Biol . Chem . 283 , 8837 – 8845 . 881 Brandt , M . E . , Vickery , L . E . , 1992 . Expression and characterization of human 882 mitochondrial ferredoxin reductase in Escherichia coli . Arch . Biochem . 883 Biophys . 294 , 735 – 740 . 884 Brdiczka , D . G . , Zorov , D . B . , Sheu , S . S . , 2006 . Mitochondrial contact sites : their role in 885 energy metabolism and apoptosis . Biochim . Biophys . Acta 1762 , 886 148 – 163 . 887 Brentano , S . T . , Black , S . M . , Lin , D . , Miller , W . L . , 1992 . CAMP post - transcriptionally 888 diminishes the abundance of adrenodoxin reductase mRNA . Proc . Natl . Acad . 889 Sci . USA 89 , 4099 – 4103 . 890 Cali , J . J . , Hsieh , C . L . , Francke , U . , Russell , D . W . , 1991 . Mutations in the bile acid 891 biosynthetic enzyme sterol 27 - hydroxylase underlie cerebrotendinous 892 xanthomatosis . J . Biol . Chem . 266 , 7779 – 7783 . 893 Cao , P . , Bulow , H . , Dumas , B . , Bernhardt , R . , 2000 . Construction and characterization 894 of a catalytic fusion protein system : P - 45011 - adrenodoxin reductase - 895 adrenodoxin . Biochim . Biophys . Acta 1476 , 253 – 264 . 896 Charman , M . , Kennedy , B . E . , Osborne , N . , Karten , B . , 2010 . MLN64 mediates egress of 897 cholesterol from endosomes to mitochondria in the absence of functional 898 Niemann - Pick Type C1 protein . J . Lipid Res . 51 , 1023 – 1034 . 899 Chen , K . S . , Prahl , J . M . , DeLuca , H . F . , 1993 . Isolation and expression of human 1 , 25 - 900 dihydroxyvitamin D3 24 - hydroxylase cDNA . Proc . Natl . Acad . Sci . USA 90 , 901 4543 – 4547 . 902 Cheng , J . B . , Motola , D . L . , Mangelsdorf , D . J . , Russell , D . W . , 2003 . De - orphanization of 903 cytochrome P450 2R1 : a microsomal vitamin D 25 - hydroxilase . J . Biol . Chem . 904 278 , 38084 – 38093 . Fig . 4 . Biosynthesis of vitamin D 3 . Ultraviolet light at 290 – 320 nm acts on the skin to cleave the B ring of 7 - dehydrocholesterol to yield cholecalciferol ( vitamin D 3 ) . Vitamin D , is converted to 25OHD by several enzymes inthe liver , principally CYP2R1 . 25OHD is activated by 1 a - hydroxylation inthe kidney , yielding the active hormone 1 , 25 ( OH ) 2 D , which acts by binding to the vitamin D receptor ( VDR ) . Both 25OHD and 1 , 25 ( OH ) 2 D may be inactivated by P450c24 to yield 24 , 25 ( OH ) 2 D or 1 , 24 , 25 ( OH ) 3 D , respectively . W . L . Miller / Molecular and Cellular Endocrinology xxx ( 2013 ) xxx – xxx 9 MCE 8497 No . of Pages 11 , Model 5G 4 May 2013 Please cite this article in press as : Miller , W . L . Steroid hormone synthesis in mitochondria . Molecular and Cellular Endocrinology ( 2013 ) , http : / / dx . doi . org / 10 . 1016 / j . mce . 2013 . 04 . 014 905 Cheng , J . B . , Levine , M . A . , Bell , N . H . , Mangelsdorf , D . J . , Russell , D . W . , 2004 . Genetic 906 evidence that the human CYP2R1 enzyme is a key vitamin D 25 - hydroxylase . 907 Proc . Natl . Acad . Sci . USA 101 , 7711 – 7715 . 908 Cherradi , N . , Chambaz , E . M . , Defaye , G . , 1995 . Organization of 3 b - hydroxysteroid 909 dehydrogenase / isomerase and cytochrome P450scc into a catalytically active 910 molecular complex in bovine adrenocortical mitochondria . J . Steroid Biochem . 911 Mol . Biol . 55 , 507 – 514 . 912 Cherradi , N . , Rossier , M . F . , Vallotton , M . B . , Timberg , R . , Friedberg , I . , Orly , J . , Wang , 913 X . J . , Stocco , D . M . , Capponi , A . M . , 1997 . Submitochondrial distribution of three 914 key steroidogenic proteins ( steroidogenic acute regulatory protein and 915 cytochrome P450scc and 3 - hydroxysteroid dehydrogenase isomerase 916 enzymes ) upon stimulation by intracellular calcium in adrenal glomerulosa 917 cells . J . Biol . Chem . 272 , 7899 – 7907 . 918 Clark , B . J . , 2012 . The mammalian START domain protein family in lipid transport in 919 health and disease . J . Endocrinol . 212 , 257 – 275 . 920 Clark , B . J . , Wells , J . , King , S . R . , Stocco , D . M . , 1994 . The puriﬁcation , cloning and 921 expression of a novel luteinizing hormone - induced mitochondrial protein in 922 MA - 10 cells mouse Leydig tumor cells . Characterization of the steroidogenic 923 acute regulatory protein ( StAR ) . J . Biol . Chem . 269 , 28314 – 28322 . 924 Dauber , A . , Nguyen , T . T . , Sochett , E . , Cole , D . E . , Horst , R . , Abrams , S . A . , Carpenter , 925 T . O . , Hirschhorn , J . N . , 2012 . Genetic defect in CYP24A1 , the vitamin D 24 - 926 hydroxylase gene , in a patient with severe infantile hypercalcemia . J . Clin . 927 Endocrinol . Metab . 97 , E268 – E274 . 928 Dilworth , F . J . , Black , S . M . , Guo , Y . D . , Miller , W . L . , Jones , G . , 1996 . Construction of a 929 P450c27 fusion enzyme – a useful tool for analysis of vitamin D3 – 25 - 930 hydroxylase activity . Biochem . J . 320 , 267 – 271 . 931 Dobs , A . S . , Schrott , H . , Davidson , M . H . , Bays , H . , Stein , E . A . , Kush , D . , Wu , M . , Mitchel , 932 Y . , Illingworth , R . D . , 2000 . Effects of high - dose simvastatin on adrenal and 933 gonadal steroidogenesis in men with hypercholesterolemia . Metabolism 49 , 934 1234 – 1238 . 935 Dong , Q . , Miller , W . L . , 2004 . Vitamin D 25 - hydroxylase deﬁciency . Mol . Genet . 936 Metab . 83 , 197 – 198 . 937 Dyson , M . T . , Kowalewski , M . P . , Manna , P . R . , Stocco , D . M . , 2009 . The differential 938 regulation of steroidogenic acute regulatory protein - mediated steroidogenesis 939 by type I and type II PKA in MA - 10 cells . Mol . Cell . Endocrinol . 300 , 94 – 103 . 940 Edouard , T . , Alos , N . , Chabot , G . , Roughley , P . , Glorieux , F . H . , Rauch , F . , 2011 . Short - 941 and long - term outcome of patients with pseudo - vitamin D deﬁciency rickets 942 treated with calcitriol . J . Clin . Endocrinol . Metab . 96 , 82 – 89 . 943 Epstein , L . F . , Orme - Johnson , N . R . , 1991 . Regulation of steroid hormone biosynthesis . 944 Identiﬁcation of precursors of a phosphoprotein targeted to the mitochondrion 945 in stimulated rat adrenal cortex cells . J . Biol . Chem . 266 , 19739 – 19745 . 946 Fan , J . , Liu , J . , Culty , M . , Papadopoulos , V . , 2010 . Acyl - coenzyme A binding domain 947 containing 3 ( ACBD3 ; PAP7 ; GCP60 ) : an emerging signaling molecule . Prog . 948 Lipid Res . 49 , 218 – 234 . 949 Fardella , C . E . , Miller , W . L . , 1996 . Molecular biology of mineralocorticoid 950 metabolism . Annu . Rev . Nutr . 16 , 443 – 470 . 951 Feldman , D . , Malloy , P . J . , Miller , W . L . , 2013 . Genetic disorders of vitamin D synthesis 952 and action . In : Thakker , R . V . , Whyte , M . P . , Eisman , J . A . , Igarashi , T . ( Eds . ) , 953 Genetics of Bone Biology and Skeletal . Academic Press ( Elsevier ) , London , UK , 954 pp . 537 – 552 . 955 Freeman , M . R . , Dobritsa , A . , Gaines , P . , Segraves , W . A . , Carlson , J . R . , 1999 . The dare 956 gene : steroid hormone production , olfactory behavior , and neural degeneration 957 in Drosophila . Development 126 , 4591 – 4602 . 958 Fu , G . K . , Lin , D . , Zhang , M . Y . H . , Bikle , D . D . , Shackleton , C . H . L . , Miller , W . L . , Portale , 959 A . A . , 1997a . Cloning of human 25 - hydroxyvitamin D 1 - hydroxylase and 960 mutations causing vitamin D - dependent rickets type I . Mol . Endocrinol . 11 , 961 1961 – 1970 . 962 Fu , G . K . , Portale , A . A . , Miller , W . L . , 1997b . Complete structure of the human gene for 963 the vitamin D 1hydroxylase , P450clDNA . Cell Biol . 16 , 1499 – 1507 . 964 Fujieda , K . , Tajima , T . , Nakae , J . , Sageshima , S . , Tachibana , K . , Suwa , S . , Sugawara , T . , 965 Strauss , J . F . I . I . I . , 1997 . Spontaneous puberty in 46 , XX subjects with congenital 966 lipoid adrenal hyperplasia . Ovarian steroidogenesis is spared to some extent 967 despite inactivating mutations in the steroidogenic acute regulatory protein 968 ( StAR ) gene . J . Clin . Invest . 99 , 1265 – 1271 . 969 Gizard , F . , Lavallee , B . , DeWitte , F . , Teissier , E . , Staels , B . , Hum , D . W . , 2002 . The 970 transcriptional regulating protein of 132 kDa ( TReP - 132 ) enhances P450scc 971 gene transcription through interaction with steroidogenic factor - 1 in human 972 adrenal cells . J . Biol . Chem . 277 , 39144 – 39155 . 973 Gucev , Z . , Tee , M . K . , Chitayat , D . , Wherrett , D . , Miller , W . L . , 2013 . Distinguishing 974 deﬁciencies of StAR and P450scc causing neonatal adrenal failure . J . Pediatr . 975 162 , 819 – 822 . 976 Harikrishna , J . A . , Black , S . M . , Szklarz , G . D . , Miller , W . L . , 1993 . Construction and 977 function of fusion enzymes of the human cytochrome P450scc system . DNA Cell 978 Biol . 12 , 371 – 379 . 979 Hasegawa , T . , Zhao , L . P . , Caron , K . M . , Majdic , G . , Suzuki , T . , Shizawa , S . , Sasano , H . , 980 Parker , K . L . , 2000 . Developmental roles of the steroidogenic acute regulatory 981 protein ( StAR ) as revealed by StAR knockout mice . Mol . Endocrinol . 14 , 1462 – 982 1471 . 983 Hauet , T . , Yao , Z . X . , Bose , H . S . , Wall , C . T . , Han , Z . , Li , W . , Hales , D . B . , Miller , W . L . , 984 Culty , M . , Papadopoulos , V . , 2005 . Peripheral - type benzodiazepine receptor - 985 mediated action of steroidogenic acute regulatory protein on cholesterol entry 986 into Leydig cell mitochondria . Mol . Endocrinol . 19 , 540 – 554 . 987 Henderson , Y . C . , Frederick , M . J . , Jayakumar , A . , Choi , Y . , Wang , M . T . , Kang , Y . , Evans , 988 R . , Spring , P . M . , Uesugi , M . , Clayman , G . L . , 2007 . Human LBP - 32 / MGR is a 989 repressor of the P450scc in human choriocarcinoma cell line JEG - 3 . Placenta 28 , 990 152 – 160 . 991 Hiller , S . , Garces , R . G . , Malia , T . J . , Orekhov , V . Y . , Colombini , M . , Wagner , G . , 2008 . 992 Solution structure of the integral human membrane protein VDAC - 1 in 993 detergent micelles . Science 321 , 1206 – 1210 . 994 Hu , M . C . , Hsu , N . C . , El Hadj , N . B . , Pai , C . I . , Chu , H . P . , Wang , C . K . L . , Chung , B . C . , 2002 . 995 Steroid deﬁciency syndromes in mice with targeted disruption of Cyp11a1 . Mol . 996 Endocrinol . 16 , 1943 – 1950 . 997 Huang , N . , Miller , W . L . , 2000 . Cloning of factors related to HIV - inducible LBP 998 proteins that regulate steroidogenic factor - 1 - independent human placental 999 transcription of the cholesterol side - chain cleavage enzyme , P450scc . J . Biol . 1000 Chem . 275 , 2852 – 2858 . 1001 Illingworth , D . , Kenney , T . A . , Orwoll , E . S . , 1982 . Adrenal function in heterozygous 1002 and homozygous hypobetalipoproteinemia . J . Clin . Endocrinol . Metab . 54 , 27 – 1003 33 . 1004 Jamin , N . , Neumann , J . M . , Ostuni , M . A . , Vu , T . K . , Yao , Z . X . , Murail , S . , Robert , J . C . , 1005 Giatzakis , C . , Papadopoulos , V . , Lacapere , J . J . , 2005 . Characterization of the 1006 cholesterol recognition amino acid consensus sequence of the peripheral - type 1007 benzodiazepine receptor . Mol . Endocrinol . 19 , 588 – 594 . 1008 Jo , Y . , King , S . R . , Khan , S . A . , Stocco , D . M . , 2005 . Involvement of protein kinase C and 1009 cyclic adenosine 3 0 , 5 0 - monophosphate - dependent kinase in steroidogenic acute 1010 regulatory protein expression and steroid biosynthesis in Leydig cells . Biol . 1011 Reprod . 73 , 244 – 255 . 1012 Joseph - Liauzun , E . , Delmas , P . , Shire , D . , Ferrara , P . , 1998 . Topological analysis of the 1013 peripheral benzodiazepine receptor in yeast mitochondrial membranes 1014 supports a ﬁve - transmembrane structure . J . Biol . Chem . 273 , 2146 – 2152 . 1015 Kim , C . J . , Kaplan , L . E . , Perwad , F . , Huang , N . , Sharma , A . , Choi , Y . , Miller , W . L . , Portale , 1016 A . A . , 2007 . Mutations in the gene for 1 - hydroxylase , CYP27B1 , in patients with 1017 vitamin D 1 - hydroxylase deﬁciency . J . Clin . Endocrinol . Metab . 92 , 3177 – 3182 . 1018 Kim , J . M . , Choi , J . H . , Lee , J . H . , Kim , G . H . , Lee , B . H . , Kim , H . S . , Shin , J . H . , Shin , C . H . , Kim , 1019 C . J . , Yu , J . , Lee , D . Y . , Cho , W . K . , Suh , B . K . , Lee , J . E . , Chung , H . R . , Yoo , H . W . , 2011 . 1020 High allele frequency of the p . Q258X mutation and identiﬁcation of a novel 1021 mis - splicing mutation in the STAR gene in Korean patients with congenital 1022 lipoid adrenal hyperplasia . Eur . J . Endocrinol . 165 , 771 – 778 . 1023 Kishida , T . , Kostetskii , I . , Zhang , Z . , Martinez , F . , Liu , P . , Walkley , S . U . , Dwyer , N . K . , 1024 Blanchette - Mackie , E . J . , Radice , G . L . , Strauss 3rd . , J . F . , 2004 . Targeted mutation 1025 of the MLN64 START domain causes only modest alterations in cellular sterol 1026 metabolism . J . Biol . Chem . 279 , 19276 – 19285 . 1027 Korkhov , V . M . , Sachse , C . , Short , J . M . , Tate , C . G . , 2010 . Three - dimensional structure 1028 of TspO by electron cryomicroscopy of helical crystals . Structure 18 , 677 – 687 . 1029 Kwon , H . J . , Abi - Mosleh , L . , Wang , M . L . , Deisenhofer , J . , Goldstein , J . L . , Brown , M . S . , 1030 Infante , R . E . , 2009 . Structure of N - terminal domain of NPC1 reveals distinct 1031 subdomains for binding and transfer of cholesterol . Cell 137 , 1213 – 1224 . 1032 Lacapere , J . J . , Papadopoulos , V . , 2003 . Peripheral - type benzodiazepine receptor : 1033 structure and function of a cholesterol - binding protein in steroid and bile acid 1034 biosynthesis . Steroids 68 , 569 – 585 . 1035 Lee , T . C . , Miller , W . L . , Auchus , R . J . , 1999 . Medroxyprogesterone acetate and 1036 dexamethasone are competitive inhibitors of different human steroidogenic 1037 enzymes . J . Clin . Endocrinol . Metab . 84 , 2104 – 2110 . 1038 Leitersdorf , E . , Reshef , A . , Meiner , V . , Levitzki , R . , Schwartz , S . P . , Dann , E . J . , Berkman , 1039 N . , Cali , J . J . , Klapholz , L . , Berginer , V . M . , 1993 . Frameshift and splice - junction 1040 mutations in the sterol 27 - hydroxylase gene cause cerebrotendinous 1041 xanthomatosis in Jews or Moroccan origin . J . Clin . Invest . 91 , 2488 – 2496 . 1042 Li , H . , Yao , Z . , Degenhardt , B . , Teper , G . , Papadopoulos , V . , 2001 . Cholesterol binding 1043 at the cholesterol recognition / interaction amino acid consensus ( CRAC ) of the 1044 peripheral - type benzodiazepine receptor and inhibition of steroidogenesis by 1045 an HIV TAT - CRAC peptide . Proc . Natl . Acad . Sci . USA 98 , 1267 – 1272 . 1046 Lin , D . , Gitelman , S . E . , Saenger , P . , Miller , W . L . , 1991 . Normal genes for the 1047 cholesterol side chain cleavage enzyme , P450scc , in congenital lipoid adrenal 1048 hyperplasia . J . Clin . Invest . 88 , 1955 – 1962 . 1049 Lin , D . , Chang , Y . J . , Strauss III , J . F . , Miller , W . L . , 1993 . The human peripheral 1050 benzodiazepine receptor gene : cloning and characterization of alternative 1051 splicing in normal tissues and in a patient with congenital lipoid adrenal 1052 hyperplasia . Genomics 18 , 643 – 650 . 1053 Lin , D . , Sugawara , T . , Strauss 3rd , J . F . , Clark , B . J . , Stocco , D . M . , Saenger , P . , Rogol , A . , 1054 Miller , W . L . , 1995 . Role of steroidogenic acute regulatory protein in adrenal and 1055 gonadal steroidogenesis . Science 267 , 1828 – 1831 . 1056 Liu , J . , Rone , M . B . , Papadopoulos , V . , 2006 . Protein - protein interactions mediate 1057 mitochondrial cholesterol transport and steroid biosynthesis . J . Biol . Chem . 281 , 1058 38879 – 38893 . 1059 Lohse , P . , Maas , S . , Sewell , A . C . , van Diggelen , O . P . , Seidel , D . , 1999 . Moleculardefects 1060 underlying Wolman disease appear to be more heterogeneous than those 1061 resulting in cholesteryl ester storage disease . J . Lipid Res . 40 , 221 – 228 . 1062 Manna , P . R . , Dyson , M . T . , Stocco , D . M . , 2009 . Regulation of the steroidogenic acute 1063 regulatory protein gene expression : present and future perspectives . Mol . Hum . 1064 Reprod . 15 , 321 – 333 . 1065 Mannella , C . A . , Forte , M . , Colombini , M . , 1992 . Toward the molecular structure of 1066 the mitochondrial channel , VDAC . J . Bioenergy Biomembr . 24 , 7 – 19 . 1067 Mast , N . , Annalora , A . J . , Lodowski , D . T . , Palczewski , K . , Stout , C . D . , Pikuleva , I . A . , 1068 2011 . Structural basis for three - step sequential catalysis by the cholesterol side 1069 chain cleavage enzyme CYP11A1 . J . Biol . Chem . 286 , 5607 – 5613 . 1070 McEnery , M . W . , Snowman , A . M . , Triﬁletti , R . R . , Snyder , S . H . , 1992 . Isolation of the 1071 mitochondrial benzodiazepine receptor : association with the voltagedependent 1072 anion channel and the adenine nucleotide carrier . Proc . Natl . Acad . Sci . USA 89 , 1073 3170 – 3174 . 1074 Midzak , A . , Akula , N . , Lecanu , L . , Papadopoulos , V . , 2011 . Novel androstenetriol 1075 interacts with the mitochondrial translocator protein and controls 1076 steroidogenesis . J . Biol . Chem . 286 , 9875 – 9887 . 10 W . L . Miller / Molecular and Cellular Endocrinology xxx ( 2013 ) xxx – xxx MCE 8497 No . of Pages 11 , Model 5G 4 May 2013 Please cite this article in press as : Miller , W . L . Steroid hormone synthesis in mitochondria . Molecular and Cellular Endocrinology ( 2013 ) , http : / / dx . doi . org / 10 . 1016 / j . mce . 2013 . 04 . 014 1077 Miller , W . L . , 1997 . Congenital lipoid adrenal hyperplasia : the human gene knockout 1078 of the steroidogenic acute regulatory protein . J . Mol . Endocrinol . 19 , 227 – 240 . 1079 Miller , W . L . , 2005 . Minireview : regulation of steroidogenesis by electron transfer . 1080 Endocrinology 146 , 2544 – 2550 . 1081 Miller , W . L . , 2007 . StAR search – what we know about how the steroidogenic acute 1082 regulatory protein mediates mitochondrial cholesterol import . Mol . Endocrinol . 1083 21 , 589 – 601 . 1084 Miller , W . L . , Auchus , R . J . , 2011 . Themolecular biology , biochemistry , and physiology 1085 of human steroidogenesis and its disorders . Endocr . Rev . 32 , 81 – 151 . 1086 Miller , W . L . , Bose , H . S . , 2011 . Early steps insteroidogenesis : intracellular cholesterol 1087 trafﬁcking . J . Lipid Res . 52 , 2111 – 2135 . 1088 Muller , A . , Muller , J . J . , Muller , Y . A . , Uhlmann , H . , Bernhardt , R . , Heinemann , U . , 1998 . 1089 New aspects of electron transfer revealed by the crystal structure of a truncated 1090 bovine adrenodoxin , Adx ( 4 - 108 ) . Structure 6 , 269 – 280 . 1091 Nakae , J . , Tajima , T . , Sugawara , T . , Arakane , F . , Hanaki , K . , Hotsubo , T . , Igarashi , N . , 1092 Igarashi , Y . , Ishii , T . , Koda , N . , Kondo , T . , Kohno , H . , Nakagawa , Y . , Tachibana , K . , 1093 Takeshima , Y . , Tsubouchi , K . , Strauss III , J . F . , Fujieda , K . , 1997 . Analysis of the 1094 steroidogenic acute regulatory protein ( StAR ) gene in Japanese patients with 1095 congential lipoid adrenal hyperplasia . Hum . Mol . Genet . 6 , 571 – 576 . 1096 Nebert , D . W . , Wikvall , K . , Miller , W . L . , 2013 . Human cytochromes P450 in health 1097 and disease . Phil . Trans . R . Soc . B 368 , 20120431 , < http : / / dx . doi . org / 10 . 1098 / 1098 rstb . 2012 . 0431 > . 1099 Norman , A . W . , 1998 . Sunlight , season , skin pigmentation , vitamin D , and 25 - 1100 hydroxyvitamin D : integral components of the vitamin D endocrine system . 1101 Am . J . Clin . Nutr . 67 , 1108 – 1110 . 1102 Ohyama , Y . , Noshiro , M . , Okuda , K . , 1991 . Cloning and expression of cDNA encoding 1103 25 - hydroxyvitamin D 3 24 - hydroxylase . FEBS Lett . 278 , 195 – 198 . 1104 Olvera - Sanchez , S . , Espinosa - Garcia , M . T . , Monreal , J . , Flores - Herrera , O . , Martinez , 1105 F . , 2011 . Mitochondrial heat shock protein participates in placental 1106 steroidogenesis . Placenta 32 , 222 – 229 . 1107 Papadopoulos , V . , Miller , W . L . , 2012 . Role of mitochondria in steroidogenesis . Best 1108 practice & research . Clin . Endocrinol . Metab . 26 , 771 – 790 . 1109 Papadopoulos , V . , Amri , H . , Li , H . , Boujrad , N . , Vidic , B . , Garnier , M . , 1997 . Targeted 1110 disruption of the peripheral - type benzodiazepine receptor gene inhibits 1111 steroidogenesis in the R2C Leydig tumor cell line . J . Biol . Chem . 272 , 32129 – 1112 32135 . 1113 Papadopoulos , V . , Baraldi , M . , Guilarte , T . R . , Knudsen , T . B . , Lacapere , J . J . , Lindemann , 1114 P . , Norenberg , M . D . , Nutt , D . , Weizman , A . , Zhang , M . R . , Gavish , M . , 2006 . 1115 Receptor based on its structure and molecular function . Trends Pharmacol . Sci . 1116 27 , 402 – 409 . 1117 Pawlak , K . J . , Prasad , M . , Thomas , J . L . , Whittal , R . M . , Bose , H . S . , 2011 . Inner 1118 mitochondrial translocase Tim50 interacts with 3 b - hydroxysteroid 1119 dehydrogenase type 2 to regulate adrenal and gonadal steroidogenesis . J . Biol . 1120 Chem . 286 , 39130 – 39140 . 1121 Pelletier , G . , Li , S . , Luu - The , V . , Tremblay , Y . , Belanger , A . , Labrie , F . , 2001 . 1122 Immunoelectron microscopic localization of three key steroidogenic enzymes 1123 ( cytochrome P450 ( scc ) , 3 b - hydroxysteroid dehydrogenase and cytochrome 1124 P450 ( c17 ) ) in rat adrenal cortex and gonads . J . Endocrinol . 171 , 373 – 383 . 1125 Penning , T . M . , 1997 . Molecular endocrinology of hydroxysteroid dehydrogenases . 1126 Endocr . Rev . 18 , 281 – 305 . 1127 Pon , L . A . , Orme - Johnson , N . R . , 1986 . Acute stimulation of steroidogenesis in corpus 1128 luteum and adrenal cortex by peptide hormones . J . Biol . Chem . 261 , 6594 – 6599 . 1129 Pon , L . A . , Hartigan , J . A . , Orme - Johnson , N . R . , 1986 . Acute ACTH regulation of adrenal 1130 corticosteroid biosynthesis : rapid accumulation of a phosphoprotein . J . Biol . 1131 Chem . 261 , 13309 – 13316 . 1132 Porter , F . D . , Herman , G . E . , 2011 . Malformation syndromes caused by disorders of 1133 cholesterol synthesis . J . Lipid Res . 52 , 6 – 34 . 1134 Prasad , M . , Thomas , J . L . , Whittal , R . M . , Bose , H . S . , 2012 . Mitochondrial 3 - 1135 hydroxysteroid dehydrogenase enzyme activity requires reversible pH - 1136 dependent conformational changes at the intermembrane space . J . Biol . Chem . 1137 287 , 9534 – 9546 . 1138 Riegelhaupt , J . J . , Waase , M . P . , Garbarino , J . , Cruz , D . E . , Breslow , J . L . , 2010 . Targeted 1139 disruption of steroidogenic acute regulatory protein D4 leads to modest weight 1140 reduction and minor alterations in lipid metabolism . J . Lipid Res . 51 , 1134 – 1141 1143 . 1142 Rodriguez - Agudo , D . , Ren , S . , Wong , E . , Marques , D . , Redford , K . , Gil , G . , Hylemon , 1143 P . B . , Pandak , W . M . , 2008 . Intracellular cholesterol transporter StarD4 binds free 1144 cholesterol and increases cholesteryl ester formation . J . Lipid Res . 49 , 1409 – 1145 1419 . 1146 Romanowski , M . J . , Soccio , R . E . , Breslow , J . L . , Burley , S . K . , 2002 . Crystal structure of 1147 the Mus musculus cholesterol - regulated START protein 4 ( StarD4 ) containing a 1148 StAR - related lipid transfer domain . Proc . Natl . Acad . Sci . USA 99 , 6949 – 6954 . 1149 Rone , M . B . , Liu , J . , Blonder , J . , Ye , X . , Veenstra , T . D . , Young , J . C . , Papadopoulos , V . , 1150 2009 . Targeting and insertion of the cholesterol - binding translocator protein 1151 into the outer mitochondrial membrane . Biochemistry 48 , 6909 – 6920 . 1152 Rone , M . B . , Midzak , A . S . , Issop , L . , Rammouz , G . , Jagannathan , S . , Fan , J . , Ye , X . , 1153 Blonder , J . , Veenstra , T . , Papadopoulos , V . , 2012 . Identiﬁcation of a dynamic 1154 mitochondrial protein complex driving cholesterol import , trafﬁcking , and 1155 metabolism to steroid hormones . Mol . Endocrinol . 26 , 1868 – 1882 . 1156 Rubtsov , P . , Karmanov , M . , Sverdlova , P . , Spirin , P . , Tiulpakov , A . , 2009 . A novel 1157 homozygous mutation in CYP11A1 gene is associated with late onset adrenal 1158 insufﬁciency and hypospadias in a 46 XY patient . J . Clin . Endocrinol . Metab . 94 , 1159 936 – 939 . 1160 Saenger , P . , Klonari , Z . , Black , S . M . , Compagnone , N . , Mellon , S . H . , Fleischer , A . , 1161 Abrams , C . A . L . , Shackleton , C . H . L . , Miller , W . L . , 1995 . Prenatal diagnosis of 1162 congenital lipoid adrenal hyperplasia . J . Clin . Endocrinol . Metab . 80 , 200 – 205 . 1163 Sahakitrungruang , T . , Tee , M . K . , Blackett , P . R . , Miller , W . L . , 2011 . Partial defect in the 1164 cholesterol side - chain cleavage enzyme P450scc ( CYP11A1 ) resembling 1165 nonclassic congenital lipoid adrenal hyperplasia . J . Clin . Endocrinol . Metab . 1166 96 , 792 – 798 . 1167 Schimmer , B . P . , White , P . C . , 2010 . Steroidogenic factor 1 : its roles in differentiation , 1168 development and disease . Mol . Endocrinol . 24 , 1322 – 1337 . 1169 Schlingmann , K . P . , Kaufmann , M . , Weber , S . , Irwin , A . , Goos , C . , John , U . , Misselwitz , J . , 1170 Klaus , G . , Kuwertz - Broking , E . , Fehrenbach , H . , Wingen , A . M . , Guran , T . , Hoenderop , 1171 J . G . , Bindels , R . J . , Prosser , D . E . , Jones , G . , Konrad , M . , 2011 . Mutations in CYP24A1 1172 and idiopathicinfantile hypercalcemia . N . Engl . J . Med . 365 , 410 – 421 . 1173 Sheftel , A . D . , Stehling , O . , Pierik , A . J . , Elsasser , H . P . , Muhlenhoff , U . , Webert , H . , 1174 Hobler , A . , Hannemann , F . , Bernhardt , R . , Lill , R . , 2010 . Humans possess two 1175 mitochondrial ferredoxins , Fdx1 and Fdx2 , with distinct roles in 1176 steroidogenesis , heme , and Fe / S cluster biosynthesis . Proc . Natl . Acad . Sci . 1177 USA 107 , 11775 – 11780 . 1178 Shen , W . J . , Patel , S . , Natu , V . , Hong , R . , Wang , J . , Azhar , S . , Kraemer , F . B . , 2003 . 1179 Interaction of hormone - sensitive lipase with steroidogenic acute regulatory 1180 protein . J . Biol . Chem . 278 , 43870 – 43876 . 1181 Solish , S . B . , Picado - Leonard , J . , Morel , Y . , Kuhn , R . W . , Mohandas , T . K . , Hanukoglu , I . , 1182 Miller , W . L . , 1988 . Human adrenodoxin reductase : two mRNAs encoded by a 1183 single gene of chromosome 17cen ? 25 are expressed in steroidogenic tissues . 1184 Proc . Natl . Acad . Sci . USA 85 , 7104 – 7108 . 1185 Stevens , V . L . , Xu , T . , Lambeth , J . D . , 1992 . Cholesterol pools in rat adrenal 1186 mitochondria : use of cholesterol oxidase to infer a complex pool structure . 1187 Endocrinology 130 , 1557 – 1563 . 1188 Stocco , D . M . , Clark , B . J . , 1996 . Regulation of the acute production of steroids in 1189 steroidogenic cells . Endocr . Rev . 17 , 221 – 244 . 1190 Stocco , D . M . , Sodeman , T . C . , 1991 . The 30 kDa mitochondrial proteins induced by 1191 hormone stimulation in MA - 10 mouse Leydig tumor cells are processed from 1192 larger precursors . J . Biol . Chem . 266 , 19731 – 19738 . 1193 Strushkevich , N . , MacKenzie , F . , Cherkesova , T . , Grabovec , I . , Usanov , S . , Park , H . W . , 1194 2011 . Structural basis for pregnenolone biosynthesis by the mitochondrial 1195 monooxygenase system . Proc . Natl . Acad . Sci . USA 108 , 10139 – 10143 . 1196 Sugawara , T . , Holt , J . A . , Driscoll , D . , Strauss III , J . F . , Lin , D . , Miller , W . L . , Patterson , D . , 1197 Clancy , K . P . , Hart , I . M . , Clark , B . J . , Stocco , D . M . , 1995 . Human steroidogenic acute 1198 regulatory protein ( StAR ) : functional activity in COS - 1 cells , tissue - speciﬁc 1199 expression , and mapping of the structural gene to 8p11 . 2 and an expressed 1200 pseudogene to chromosome 13 . Proc . Natl . Acad . Sci . USA 92 , 4778 – 4782 . 1201 Tajima , T . , Fujieda , K . , Kouda , N . , Nakae , J . , Miller , W . L . , 2001 . Heterozygous 1202 mutation in the cholesterol side chain cleavage enzyme ( P450scc ) gene in a 1203 patient with 46 , XY sex reversal and adrenal insufﬁciency . J . Clin . Endocrinol . 1204 Metab . 86 , 3820 – 3825 . 1205 Tee , M . K . , Abramsohn , M . , Loewenthal , N . , Harris , M . , Siwach , S . , Kaplinsky , A . , 1206 Markus , B . , Birk , O . , Shefﬁeld , V . C . , Pavari , R . , Hershkovitz , E . , Miller , W . L . , 2013 . 1207 Varied clinical presentations with mutations in CYP11A1 encoding the 1208 cholesterol side chain cleavage enzyme , P450scc . J . Clin . Endocrinol . Metab . 1209 98 , 713 – 720 . 1210 Thomas , J . L . , Myers , R . P . , Strickler , R . C . , 1989 . Human placental 3 - hydroxy - 5 - ene - 1211 steroid dehydrogenase and steroid 5 D 4 - ene - isomerase : puriﬁcation from 1212 mitochondria and kinetic proﬁles , biophysical characterization of the puriﬁed 1213 mitochondrial and microsomal enzymes . J . Steroid Biochem . 33 , 209 – 217 . 1214 Thorsell , A . G . , Lee , W . H . , Persson , C . , Siponen , M . I . , Nilsson , M . , Busam , R . D . , 1215 Kotenyova , T . , Schuler , H . , Lethio , L . , 2011 . Comparative structural analysis of 1216 lipid binding START domains . PLoS ONE 6 , e19521 – e19532 . 1217 Tsujishita , Y . , Hurley , J . H . , 2000 . Structure and lipid transport mechanism of a StAR - 1218 related domain . Nat . Struct . Biol . 7 , 408 – 414 . 1219 Tuckey , R . C . , Headlam , M . J . , Bose , H . S . , Miller , W . L . , 2002 . Transfer of cholesterol 1220 between phospholipid vesicles mediated by the steroidogenic acute regulatory 1221 protein ( StAR ) . J . Biol . Chem . 277 , 47123 – 47128 . 1222 Vanier , M . T . , Millat , G . , 2003 . Niemann - PickdiseasetypeC . Clin . Genet . 64 , 269 – 281 . 1223 Wang , J . T . , Lin , C . J . , Burridge , S . M . , Fu , G . K . , Labuda , M . , Portale , A . A . , Miller , W . L . , 1224 1998 . Genetics of vitamin D 1 a - hydroxylase deﬁciency in 17 families . Am . J . 1225 Hum . Genet . 63 , 1694 – 1702 . 1226 White , P . C . , Curnow , K . M . , Pascoe , L . , 1994 . Disorders of steroid 11 - hydroxylase 1227 isozymes . Endocr . Rev . 15 , 421 – 438 . 1228 Xie , Z . J . , Munson , S . J . , Huang , N . , Portale , A . A . , Miller , W . L . , Bikle , D . D . , 2002 . The 1229 mechanism of 1 , 25 - dihydroxyvitamin D3 auto - regulation in keratinocytes . J . 1230 Biol . Chem . 277 , 36987 – 36990 . 1231 Xu , S . , Benoff , B . , Liou , H . L . , Lobel , P . , Stock , A . M . , 2007 . Structural basis of sterol 1232 binding by NPC2 , a lysosomal protein deﬁcient in Niemann - Pick type C2 1233 disease . J . Biol . Chem . 282 , 23525 – 23531 . 1234 Yang , X . , Iwamoto , K . , Wang , M . , Artwohl , J . , Mason , J . I . , Pang , S . , 1993 . Inherited 1235 congenital adrenal hyperplasia in the rabbit is caused by a deletion in the gene 1236 encoding cytochrome P450 cholesterol side - chain cleavage enzyme . 1237 Endocrinology 132 , 1977 – 1982 . 1238 Yaworsky , D . C . , Baker , B . Y . , Bose , H . S . , Best , K . B . , Jensen , L . B . , Bell , J . D . , Baldwin , M . A . , 1239 Miller , W . L . , 2005 . PH - dependent interactions of the carboxyl - terminal helix of 1240 steroidogenic acute regulatory protein withsynthetic membranes . J . Biol . Chem . 1241 280 , 2045 – 2054 . 1242 Zhang , M . , Liu , P . , Dwyer , N . K . , Christenson , L . K . , Fujimoto , T . , Martinez , F . , Comly , 1243 M . , Hanover , J . A . , Blanchette - Mackie , E . J . , Strauss 3rd , J . F . , 2002 . MLN64 1244 mediates mobilization of lysosomal cholesterol to steroidogenic 1245 mitochondria . J . Biol . Chem . 277 , 33300 – 33310 . 1246 Ziegler , G . A . , Vonrhein , C . , Hanukoglu , I . , Schulz , G . E . , 1999 . The structure of 1247 adrenodoxin reductase of mitochondrial P450 systems : electron transfer for 1248 steroid biosynthesis . J . Mol . Biol . 289 , 981 – 990 . 1249 W . L . Miller / Molecular and Cellular Endocrinology xxx ( 2013 ) xxx – xxx 11 MCE 8497 No . of Pages 11 , Model 5G 4 May 2013 Please cite this article in press as : Miller , W . L . Steroid hormone synthesis in mitochondria . Molecular and Cellular Endocrinology ( 2013 ) , http : / / dx . doi . org / 10 . 1016 / j . mce . 2013 . 04 . 014